Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,Steroid hormone biosynthesis,0.7570693390348786,2.0010267535097728,0.0,0.016800625139540074,0.014,7/17,4.47%,CYP1A1;HSD3B1;CYP11A1;CYP3A5;CYP3A4;COMT;CYP19A1
prerank,Thyroid hormone synthesis,-0.5861955855085846,-1.9900051705617536,0.0,0.025921506231768764,0.032,13/42,12.03%,ATP1B1;GPX7;DUOXA2;ATP1B2;CREB3L4;CREB5;GNAQ;ATF2;GPX8;ITPR1;SLC26A4;ASGR2;CREB3L1
prerank,Ovarian steroidogenesis,0.630182517298916,1.814332153273271,0.003663003663003663,0.1344050011163206,0.2,11/23,6.63%,CYP1A1;HSD3B1;FSHR;CYP11A1;PTGS2;ACOT2;ALOX5;CYP19A1;IGF1R;STAR;ADCY7
prerank,Prion diseases,0.6477637227303737,1.7784916359577385,0.0038022813688212928,0.13520503088487013,0.282,10/19,18.94%,C9;MAPK3;BAX;MAP2K1;PRKACB;HSPA1A;FYN;SOD1;ELK1;EGR1
prerank,Primary immunodeficiency,0.64040892861081,1.752398621620646,0.0035842293906810036,0.13140488948425988,0.332,8/21,7.33%,ICOS;CD8B;RFX5;CD19;TAP2;JAK3;LCK;IKBKG
prerank,Metabolism of xenobiotics by cytochrome P450,0.6047171144019049,1.750857425490568,0.0034129692832764505,0.10656396517079705,0.336,7/25,5.65%,CYP1A1;ALDH1A3;DHDH;CYP3A5;CYP3A4;GSTP1;CBR1
prerank,C-type lectin receptor signaling pathway,0.470144065147753,1.729926593249536,0.0035211267605633804,0.11120413782838431,0.392,17/74,8.72%,CBLB;CLEC4E;CCL22;PTGS2;JUN;PLCG2;CALML4;CCL17;MAPK3;CALML5;NFKB1;NLRP3;IKBKG;CASP8;RELB;MALT1;PIK3R1
prerank,T cell receptor signaling pathway,0.47199757861913244,1.7169586365377425,0.003861003861003861,0.11177558766306253,0.436,14/69,8.72%,CBLB;ICOS;CD8B;VAV1;JUN;PAK6;NFKBIE;MAPK3;CD3G;NFKB1;LCK;IKBKG;MALT1;PIK3R1
prerank,Chemical carcinogenesis,0.5871637613507519,1.7005664385469195,0.007067137809187279,0.11610432016075017,0.496,7/26,5.65%,CYP1A1;ALDH1A3;CYP3A5;PTGS2;CYP3A4;GSTP1;CBR1
prerank,Biosynthesis of unsaturated fatty acids,-0.5673722540876939,-1.6958319646579658,0.0,0.33392999204455054,0.514,7/23,5.63%,ELOVL2;SCD5;ELOVL7;TECR;HACD1;HACD3;HSD17B12
prerank,Morphine addiction,0.5397614975010065,1.6931624643997543,0.007462686567164179,0.10933740170176874,0.518,12/35,12.48%,GRK5;GABRP;GNG7;GNGT1;GRK2;ADCY7;ARRB2;GNAI1;PDE3B;PDE8A;GRK4;PRKACB
prerank,ECM-receptor interaction,0.5542162799326849,1.6618335117209786,0.011857707509881422,0.13248492967180175,0.618,7/30,6.98%,THBS4;THBS2;ITGA3;CD44;COL1A1;LAMA1;COL1A2
prerank,Glycerophospholipid metabolism,-0.45169133088446545,-1.65185777422299,0.009009009009009009,0.3176655175461858,0.62,24/63,20.57%,MBOAT2;SELENOI;PLD1;LPCAT3;PLD3;PEMT;AGPAT5;ETNK1;CDS1;GPCPD1;CDIPT;ETNPPL;LYPLA1;PLPP5;AGPAT3;PHOSPHO1;CEPT1;PLPP2;LCLAT1;LCAT;PLA2G6;GNPAT;LPCAT2;PLPP1
prerank,Ribosome,0.4189896402665433,1.6422921554065295,0.007272727272727273,0.14509630802330065,0.684,65/125,32.77%,RPS29;RPL39;RPS12;RPL36A;RPS4X;RPL23;RPS27;RPL37A;MRPL33;RPS24;RPL22;RPL12;RPL36AL;RPL37;RPS23;RPL24;RPS27A;RPL11;RPL7;RPL9;RPL34;RPL23A;RPL35A;RPL4;RPS21;RPL5;RPS17;RPS3;RPS20;RPL3;MRPS18C;RPS6;RPS15A;RPL26;RPL27A;RPS26;RPL35;RPL14;RPL21;RPS28;MRPS21;RPL10A;RPS14;RPL10;RPL30;RPS2;RPL6;RPS3A;RPL17;RPL38;RPLP1;RPL7A;RPS15;RPS7;RPS25;RPS8;RPLP2;RPL27;MRPS14;RPSA;RPS9;RPS5;RPS10;RPS11;RPL32
prerank,Carbohydrate digestion and absorption,-0.5891111223561607,-1.6363104721798014,0.02608695652173913,0.2698886237072395,0.654,7/17,16.00%,ATP1B1;ATP1B2;AKT1;G6PC3;ATP1B3;PIK3CB;AKT3
prerank,Fatty acid elongation,-0.5510323588570504,-1.5948691168209879,0.026905829596412557,0.29276054097056486,0.728,11/23,16.66%,ELOVL2;ELOVL7;TECR;HACD1;HACD3;PPT2;HSD17B12;ECHS1;ELOVL1;ELOVL6;MECR
prerank,Cytokine-cytokine receptor interaction,-0.4303201514896205,-1.5645102987273392,0.008438818565400843,0.3054671616724123,0.798,21/67,10.71%,TGFBR1;TNFRSF6B;CXCL16;CXCL12;CXCL14;TNFRSF11B;GDF9;IL1RAP;FAS;TNFSF12;BMP15;CCL1;CSF1R;TNFRSF10D;IFNGR1;TNFRSF12A;BMP4;CXCR4;IFNAR1;IL2RB;CLCF1
prerank,Hematopoietic cell lineage,0.512692973359426,1.5629733307705853,0.015503875968992248,0.26420983106348145,0.866,7/30,5.30%,CD8B;ITGA3;CD19;CD44;IL11RA;CD24;CD3G
prerank,Platelet activation,0.41700162656854195,1.5626387413631868,0.007352941176470588,0.24462448692187475,0.868,19/79,12.48%,PTGS1;GUCY1B1;F2;NOS3;PLCG2;MYLK;COL1A1;FGB;FCGR2A;MAPK3;ARHGEF1;ADCY7;COL1A2;PIK3R1;APBB1IP;GNAI1;VASP;MAPK13;PRKACB
prerank,Insulin secretion,-0.47067151237251215,-1.5453023160683694,0.01818181818181818,0.2999488578247528,0.842,8/39,5.13%,ATP1B1;ATP1B2;CREB3L4;PCLO;CREB5;GNAQ;ATF2;KCNN2
prerank,Fat digestion and absorption,0.5660717303815753,1.5377804404746112,0.055970149253731345,0.27755318470321816,0.916,4/18,3.20%,FABP2;APOA1;ABCG5;PNLIP
prerank,Glycosylphosphatidylinositol (GPI)-anchor biosynthesis,-0.5159367881320598,-1.5334570263177874,0.04741379310344827,0.29333233890214794,0.872,18/24,32.11%,PIGM;PIGU;PGAP1;DPM2;GPAA1;PIGV;PIGC;PIGW;PIGX;PIGG;PIGB;PIGT;PIGZ;PIGL;PIGO;PIGK;PIGH;PIGA
prerank,Focal adhesion,0.38652517177116247,1.509054674588779,0.014234875444839857,0.3243320681699784,0.94,34/117,16.94%,MYL7;THBS4;THBS2;ITGA3;CAV1;VAV1;JUN;MYLK;PAK6;COL1A1;LAMA1;FLT1;IGF1R;MAPK3;DOCK1;COL1A2;VEGFB;PIK3R1;VASP;MAP2K1;PXN;CRK;RAPGEF1;PDGFA;FYN;CCND3;PTK2;FN1;LAMB1;FLNA;ELK1;CRKL;BIRC3;PRKCA
prerank,HIF-1 signaling pathway,0.40559951533739586,1.5021547929459222,0.017985611510791366,0.3153117325295825,0.944,23/74,18.24%,HMOX1;EGLN3;TF;NOS3;PLCG2;NOS2;FLT1;TEK;CAMK2G;IGF1R;MAPK3;NFKB1;CDKN1B;MKNK2;PIK3R1;IL6R;MAP2K1;HKDC1;CREBBP;EGLN1;PRKCA;RELA;HK1
prerank,Neurotrophin signaling pathway,0.3929401387867835,1.5019648628942999,0.010638297872340425,0.29775225562428587,0.946,36/91,23.40%,IRAK3;JUN;PLCG2;CALML4;NFKBIE;NTF4;BEX3;ARHGDIB;CAMK2G;MAPK3;CALML5;BAX;NFKB1;IRAK1;PIK3R1;PSEN2;MAP2K1;MAPK13;CRK;RAPGEF1;MAPK7;ZNF274;IKBKB;GAB1;CALM1;CRKL;MAP3K1;RELA;PRDM4;SHC1;RAP1A;ABL1;MAP3K5;RAF1;MAGED1;PLCG1
prerank,Aldosterone-regulated sodium reabsorption,-0.5403132065589649,-1.501120665424866,0.0430622009569378,0.3252894899672943,0.908,6/20,15.50%,ATP1B1;ATP1B2;SCNN1A;ATP1B3;SGK1;PIK3CB
prerank,Lysosome,-0.36744253586475667,-1.461392803447204,0.009433962264150943,0.3810461416070008,0.952,36/104,20.79%,GALC;AP3M2;CTSS;HGSNAT;CTSA;GM2A;LIPA;CTSK;CLN3;CD164;PPT2;CD68;SLC17A5;MCOLN1;ATP6V0C;SGSH;MFSD8;LAMP2;GNPTG;ASAH1;ACP2;ATP6V0A1;FUCA1;AP3M1;ATP6V0B;ATP6V0D1;CTSD;GBA;NPC2;GLA;GGA1;GLB1;ATP6AP1;LAPTM4B;AP1S1;CLN5
prerank,Regulation of actin cytoskeleton,0.362166157293561,1.4608346272601362,0.003472222222222222,0.3769473592815857,0.97,41/135,20.63%,MYL7;FGD1;ITGA3;F2;VAV1;ARPC1B;MYLK;ARHGEF7;PAK6;SCIN;MAPK3;DIAPH2;LIMK2;DOCK1;ARHGEF1;FGF2;PFN2;EZR;PIK3R1;GSN;FGFR3;MAP2K1;PXN;DIAPH3;BAIAP2;CYFIP1;PIP4K2B;CRK;PDGFA;PTK2;FN1;PIKFYVE;LIMK1;CRKL;SPATA13;ACTB;MYH9;WASL;PAK2;TMSB4X;BCAR1
prerank,Fc gamma R-mediated phagocytosis,0.4019283621001199,1.4592906898325964,0.02888086642599278,0.36115028025522616,0.974,31/69,23.60%,VAV1;ARPC1B;PLCG2;SPHK2;FCGR2A;SCIN;MAPK3;LIMK2;INPP5D;MYO10;INPPL1;PIK3R1;GSN;VASP;MAP2K1;WASF3;CRK;PLD2;MARCKS;LIMK1;CRKL;PRKCA;BIN1;PLA2G4B;PLA2G4A;WASL;LYN;RAF1;PLCG1;HCK;ARPC5
prerank,Mineral absorption,-0.44901741874343715,-1.4554684156482456,0.0611353711790393,0.3570791446686435,0.96,6/32,1.19%,ATP1B1;CYBRD1;ATP1B2;STEAP1;SLC26A3;STEAP2
prerank,Mucin type O-glycan biosynthesis,0.5601071012019909,1.4524867677691802,0.06844106463878327,0.3577333110069212,0.976,5/15,14.32%,GCNT3;GCNT4;ST3GAL2;GALNT2;GALNT12
prerank,Leishmaniasis,0.4547448728170698,1.4487354434728543,0.03375527426160337,0.34927013895533654,0.978,10/34,11.79%,PTGS2;JUN;NOS2;FCGR2A;MAPK3;NFKB1;IRAK1;CYBA;TAB1;MAPK13
prerank,cGMP-PKG signaling pathway,-0.3735377324678084,-1.4475966422771964,0.021834061135371178,0.34562008309025016,0.966,15/91,5.27%,ATP1B1;RGS2;ATP1B2;PLN;NPPC;CREB3L4;CREB5;ADRB2;MYH7;GNAQ;AKT1;ATF2;BAD;ATP2A3;NFATC3
prerank,Propanoate metabolism,-0.46176947328791607,-1.4447075641543319,0.06550218340611354,0.3253676845562287,0.966,7/29,16.93%,LDHC;ABAT;ALDH6A1;ECHS1;DBT;ACACA;SUCLA2
prerank,Basal cell carcinoma,0.4649430854546624,1.4393794079734552,0.04597701149425287,0.3525949379934645,0.978,10/35,14.48%,WNT11;WNT16;PTCH1;BAX;WNT6;TCF7;AXIN1;DVL2;GADD45A;TCF7L2
prerank,VEGF signaling pathway,0.436757906356588,1.4379655762651924,0.05017921146953405,0.34049962627527497,0.978,19/43,23.40%,PTGS2;NOS3;PLCG2;CASP9;SPHK2;MAPK3;MAPKAPK3;PIK3R1;MAP2K1;PXN;MAPK13;PTK2;PRKCA;PLA2G4B;PLA2G4A;PPP3CB;PPP3CC;RAF1;PLCG1
prerank,Drug metabolism,0.42828192982993657,1.4354645911597577,0.037800687285223365,0.3329123874376721,0.978,7/49,5.89%,ALDH1A3;CYP3A5;AOX1;CYP3A4;DPYS;GSTP1;TK2
prerank,Porphyrin and chlorophyll metabolism,0.5067474418805183,1.4337221925676642,0.06037735849056604,0.32391605269033263,0.978,5/22,16.52%,HMOX1;CP;FECH;GUSB;HEPH
prerank,Arginine and proline metabolism,0.4515402928770657,1.4283866754309125,0.0625,0.3217042780840504,0.978,15/35,21.06%,L3HYPDH;GATM;CNDP1;NOS3;NOS2;P4HA2;SMOX;ALDH2;ODC1;ALDH18A1;SMS;ALDH9A1;ALDH7A1;ALDH4A1;LAP3
prerank,ErbB signaling pathway,0.40128309246152083,1.4169986898904525,0.05734767025089606,0.33441244325370245,0.986,19/65,16.94%,CBLB;ABL2;JUN;PLCG2;PAK6;CAMK2G;ERBB3;MYC;STAT5B;MAPK3;CDKN1B;PIK3R1;MAP2K1;CRK;PTK2;GAB1;ELK1;CRKL;PRKCA
prerank,Antigen processing and presentation,0.4475376968187734,1.4094111845100397,0.11619718309859155,0.3393554843236692,0.99,6/32,5.98%,CD8B;HSPA6;RFX5;TAP2;IFI30;HSPA2
prerank,beta-Alanine metabolism,0.5104461356756216,1.40392612796475,0.1018867924528302,0.33915744739820314,0.99,9/19,19.23%,ALDH1A3;CNDP1;DPYS;AOC2;SMOX;ALDH2;SMS;ALDH9A1;ALDH7A1
prerank,Retinol metabolism,0.4936096701434996,1.393409567956723,0.09420289855072464,0.3510530624395326,0.996,5/22,1.98%,CYP1A1;CYP26B1;CYP3A5;AOX1;CYP3A4
prerank,MAPK signaling pathway,0.33194477286306345,1.3907338842511123,0.017241379310344827,0.3449160598924011,0.996,60/192,17.72%,DUSP10;HSPA6;PTPN5;JUN;MAPK8IP1;NTF4;FLT1;TEK;IGF1R;RPS6KA4;ERBB3;MYC;MAPK3;HSPA2;NFKB1;MAP4K2;STMN1;IRAK1;FGF2;CACNB3;JUND;IKBKG;VEGFB;SRF;MKNK2;RELB;MAPKAPK3;DUSP6;MAP3K12;ARRB2;DUSP3;FGFR3;MAP3K13;MAP2K1;TAOK2;TAB1;TAOK3;MAPK13;DAXX;PRKACB;HSPA1A;GADD45A;CRK;MAPK7;PDGFA;DUSP8;IKBKB;KITLG;PPM1A;FLNA;ELK1;NFKB2;CRKL;DDIT3;PRKCA;PLA2G4B;MAPKAPK5;MAP3K1;RELA;MAP4K4
prerank,Glycosaminoglycan biosynthesis,0.4544518743029357,1.3882112193030047,0.07509881422924901,0.3403626646572896,0.996,6/28,8.04%,UST;B4GALT2;CSGALNACT2;DSE;HS6ST1;ST3GAL2
prerank,Steroid biosynthesis,-0.5272348525632837,-1.3855677846526528,0.12033195020746888,0.43543773913702316,0.984,6/15,13.32%,MSMO1;LIPA;SOAT1;FDFT1;HSD17B7;CYP2R1
prerank,One carbon pool by folate,0.5307578568998702,1.383746480078058,0.11740890688259109,0.3384125920964501,0.998,6/16,17.59%,MTR;SHMT1;MTHFD2L;ALDH1L2;MTHFD1L;MTHFR
prerank,Cell cycle,-0.3371820864594416,-1.3805698729417961,0.025,0.41992840095465395,0.988,28/115,18.94%,WEE2;SKP2;E2F3;CDKN1C;GADD45G;CDK2;SMC1A;PLK1;YWHAZ;EP300;CCND2;CCNB1;CCNB2;MAD2L2;ATM;CCNE1;RBL1;MDM2;YWHAE;CCNE2;CDC20;E2F1;ANAPC11;BUB3;ORC5;ORC4;ORC1;CDC14A
prerank,Tryptophan metabolism,0.4852084849883931,1.3745833100398779,0.0963855421686747,0.34744822242359774,0.998,4/23,5.35%,CYP1A1;AOX1;KYNU;IL4I1
prerank,Regulation of lipolysis in adipocytes,0.4531418963200435,1.3717522086118976,0.1037037037037037,0.34382993652919974,0.998,9/26,12.48%,PTGS1;PTGS2;MGLL;ADCY7;PNPLA2;PIK3R1;GNAI1;PDE3B;PRKACB
prerank,Measles,0.3586038563344202,1.3704594639276388,0.04,0.33694587085410926,0.998,17/88,8.97%,CBLB;HSPA6;JUN;CASP9;JAK3;STAT5B;BAX;CD3G;HSPA2;NFKB1;IRAK1;IKBKG;IRF7;CASP8;CDKN1B;PIK3R1;CSNK2A2
prerank,AGE-RAGE signaling pathway in diabetic complications,0.3891651084579679,1.3647388741430502,0.04727272727272727,0.3400991413382572,0.998,18/61,11.79%,JUN;NOS3;PLCG2;COL1A1;PIM1;PLCD1;STAT5B;MAPK3;BAX;SMAD4;PLCD3;NFKB1;COL1A2;VEGFB;CDKN1B;PIK3R1;AGER;MAPK13
prerank,Long-term depression,0.4296433169601677,1.3578929222727614,0.07364341085271318,0.3442864948708006,1.0,23/35,34.65%,GUCY1B1;IGF1R;MAPK3;GNA11;PPP2CB;GNAI1;MAP2K1;PRKCA;PLA2G4B;PLA2G4A;LYN;PLCB4;RAF1;GNAS;GNAI2;MAPK1;MAP2K2;BRAF;GUCY1A2;ITPR2;KRAS;PRKG1;NRAS
prerank,Cellular senescence,-0.33389774404306244,-1.3554521580122563,0.03111111111111111,0.4612503314770618,0.996,36/126,17.48%,TGFBR1;SERPINE1;E2F3;AKT1;MCU;RASSF5;GADD45G;CDK2;NFATC3;EIF4EBP1;ITPR1;CCND2;RAD1;RRAS;CCNB1;TSC1;CCNB2;HIPK3;BTRC;LIN9;ATM;CCNE1;RBL1;MDM2;TRAF3IP2;TSC2;IL6;LIN54;VDAC1;PIK3CB;CCNE2;E2F1;AKT3;MTOR;NBN;TRPM7
prerank,Circadian entrainment,0.4057427154016334,1.3539365713525,0.07220216606498195,0.34284352619918596,1.0,23/45,30.55%,GUCY1B1;GNG7;CALML4;GNGT1;CAMK2G;MAPK3;CALML5;ADCY7;PER1;GNAI1;PRKACB;CALM1;PRKCA;PLCB4;GNAS;GNAI2;GNB2;MAPK1;CACNA1H;CAMK2D;GNG12;CALM3;GNG11
prerank,Salivary secretion,-0.4144529271646643,-1.351913897270762,0.11403508771929824,0.44389458249489133,0.996,13/35,18.43%,ATP1B1;ATP1B2;LPO;ADRB2;GNAQ;ITPR1;SLC12A2;ATP2B1;ATP1B3;SLC9A1;CST3;VAMP2;ADCY3
prerank,GABAergic synapse,0.42400898808361,1.349982240013362,0.09505703422053231,0.34303276400982363,1.0,12/39,18.04%,GABRP;GNG7;GNGT1;SLC6A1;ADCY7;TRAK2;GNAI1;SLC12A5;PRKACB;SLC6A11;PRKCA;GLUL
prerank,IL-17 signaling pathway,0.39766533755420336,1.3451343717963353,0.08118081180811808,0.34549578248629104,1.0,18/51,17.71%,FOSB;PTGS2;JUN;CXCL2;CCL17;MAPK3;NFKB1;JUND;IKBKG;CASP8;MAPK4;HSP90AB1;IL17RA;MAPK13;MAPK7;IKBKB;SRSF1;RELA
prerank,Pathways in cancer,0.29510485264874403,1.3418313693037047,0.006514657980456026,0.34486997522831414,1.0,85/320,16.94%,WNT11;WNT16;HMOX1;ITGA3;F2;GNG7;PTCH1;EGLN3;PTGS2;JUN;IL15RA;DAPK3;PLCG2;CALML4;NOS2;GSTP1;CASP9;LPAR3;PIM1;GNGT1;RXRA;LAMA1;JAK3;CAMK2G;IGF1R;MYC;STAT5B;MAPK3;CALML5;BAX;SMAD4;ARHGEF1;NFKB1;FGF2;WNT6;ADCY7;GNA11;RALB;TCF7;IKBKG;CTBP1;VEGFB;CASP8;CDKN1B;HEYL;MLH1;PIK3R1;IL6R;GNAI1;FGFR3;DAPK1;TXNRD2;MAP2K1;HSP90AB1;AXIN1;RALBP1;JAG2;DVL2;PIM2;EPAS1;PRKACB;GADD45A;LRP5;KEAP1;MSH3;CRK;CREBBP;IL23A;PDGFA;TCF7L2;CCND3;IKBKB;PTK2;FN1;LAMB1;KITLG;NCOA1;EGLN1;CCNA1;CALM1;ELK1;NFKB2;CRKL;BIRC3;PRKCA
prerank,Herpes simplex virus 1 infection,-0.3047714155155192,-1.3365715783960774,0.028169014084507043,0.4570147912431126,0.996,48/193,16.52%,ZNF214;TAPBP;ZNF471;TRADD;ZNF606;ZFP14;FAS;AKT1;STAT1;ZNF132;BAD;ZNF569;ZNF684;ZNF624;ZNF782;ZNF568;NXF1;EIF4EBP1;IRAK4;ZIM3;ZNF473;EIF2B1;ZNF3;IFNGR1;CASP3;PDIA3;ZNF793;IFNAR1;TSC1;SRPK1;TBK1;ZNF565;ZNF557;TSC2;ZNF792;ZNF248;IL6;ZNF331;ZNF114;ZNF300;EIF2AK1;CGAS;HCFC2;PIK3CB;ZNF527;AKT3;BIRC2;MTOR
prerank,Adrenergic signaling in cardiomyocytes,-0.3611583282725087,-1.3362220368982674,0.049107142857142856,0.4336033999078843,0.996,11/77,5.10%,ATP1B1;ATP1B2;PLN;CREB3L4;CREB5;ADRB2;MYH7;GNAQ;AKT1;ATF2;CACNA2D2
prerank,Aldosterone synthesis and secretion,-0.37849025766783967,-1.3282379035333625,0.06493506493506493,0.429839565102095,0.998,10/52,6.98%,ATP1B1;LDLR;ATP1B2;CREB3L4;CREB5;GNAQ;ATF2;NR4A1;PRKD2;ITPR1
prerank,Melanogenesis,0.3732444645456496,1.3179643309582274,0.10830324909747292,0.38976334003125696,1.0,19/58,16.94%,WNT11;WNT16;CALML4;CAMK2G;MAPK3;CALML5;WNT6;ADCY7;TCF7;POMC;GNAI1;MAP2K1;DVL2;PRKACB;CREBBP;TCF7L2;KITLG;CALM1;PRKCA
prerank,PI3K-Akt signaling pathway,0.30576882536940453,1.3043565201281675,0.04895104895104895,0.41346993038218754,1.0,46/194,15.93%,THBS4;THBS2;ITGA3;CD19;GNG7;NOS3;CASP9;COL1A1;LPAR3;THEM4;GNGT1;RXRA;LAMA1;NTF4;JAK3;FLT1;TEK;IGF1R;ERBB3;MYC;YWHAG;MAPK3;NFKB1;FGF2;PPP2R3A;COL1A2;IKBKG;VEGFB;CDKN1B;PIK3R1;PPP2R2B;PPP2CB;IL6R;FGFR3;MAP2K1;HSP90AB1;EIF4B;PDGFA;CCND3;YWHAH;MTCP1;IKBKB;PTK2;FN1;LAMB1;KITLG
prerank,Endocrine and other factor-regulated calcium reabsorption,-0.4348611550968461,-1.3022174294035647,0.13983050847457626,0.4745741308987133,1.0,3/25,3.02%,ATP1B1;ATP1B2;GNAQ
prerank,B cell receptor signaling pathway,0.3782639016158371,1.2985497954181981,0.11583011583011583,0.4182022276797896,1.0,14/53,10.68%,CD19;VAV1;JUN;PLCG2;NFKBIE;MAPK3;NFKB1;IFITM1;INPP5D;IKBKG;MALT1;INPPL1;PIK3R1;MAP2K1
prerank,FoxO signaling pathway,-0.34591204446817925,-1.2977994853176347,0.07983193277310924,0.4636068320435862,1.0,26/88,16.70%,TGFBR1;SKP2;SOS1;SOS2;AKT1;GADD45G;CDK2;HOMER1;G6PC3;PLK1;PRMT1;EP300;CCND2;CCNB1;CCNB2;GABARAP;ATM;PRKAB1;MDM2;BCL2L11;IL6;FBXO32;SGK1;PIK3CB;AKT3;PRKAG1
prerank,Amoebiasis,0.3906270938471945,1.2974609657899867,0.09266409266409266,0.41192837104555563,1.0,15/46,17.71%,C9;NOS2;COL1A1;LAMA1;NFKB1;SERPINB1;GNA11;COL1A2;PIK3R1;PRKACB;PTK2;FN1;LAMB1;PRKCA;RELA
prerank,Cell adhesion molecules (CAMs),0.39973010033570666,1.2966983869085922,0.10526315789473684,0.4046448437863695,1.0,7/46,5.58%,ICOS;CD8B;ICAM3;ESAM;NLGN3;L1CAM;CLDN8
prerank,Pancreatic secretion,-0.3937158341696648,-1.2885306194003658,0.14847161572052403,0.463206046141607,1.0,11/37,15.31%,ATP1B1;ATP1B2;SLC26A3;GNAQ;ATP2A3;ITPR1;RAB8A;SLC12A2;ATP2B1;ATP1B3;SLC9A1
prerank,Proteoglycans in cancer,0.31622473617146457,1.2770635255758986,0.0851063829787234,0.4441165252660564,1.0,37/135,16.94%,WNT11;WNT16;IHH;CAV1;CD44;PTCH1;PLCG2;DCN;TFAP4;CAMK2G;IGF1R;ERBB3;MYC;MAPK3;ARHGEF1;FGF2;WNT6;EZR;PIK3R1;CTTN;MAP2K1;PXN;ANK3;NANOG;MAPK13;PRKACB;PLAU;EIF4B;PTK2;TWIST1;FN1;DROSHA;CD63;GAB1;FLNA;ELK1;PRKCA
prerank,Retrograde endocannabinoid signaling,0.32837751129519394,1.2644582958689352,0.10606060606060606,0.4665479721694438,1.0,19/88,17.17%,GABRP;GNG7;PTGS2;GNGT1;MAPK3;MGLL;ADCY7;NDUFA1;NDUFB1;GNAI1;NDUFA5;NDUFB3;MAPK13;PRKACB;NDUFC1;NDUFS4;NDUFA6;PRKCA;ND3
prerank,NF-kappa B signaling pathway,0.3558713490198474,1.263568843288442,0.13147410358565736,0.45932909131502564,1.0,28/59,25.71%,PTGS2;PLCG2;CXCL2;NFKB1;IRAK1;CCL19;LCK;IKBKG;RELB;MALT1;CSNK2A2;TAB1;PIAS4;BLNK;PLAU;IKBKB;ZAP70;NFKB2;BIRC3;RELA;LY96;BCL2A1;LYN;TRAF3;PLCG1;PARP1;CARD10;CXCL8
prerank,Folate biosynthesis,0.46512902289067254,1.2559059570733664,0.18382352941176472,0.4687703837954025,1.0,2/17,5.65%,MOCOS;CBR1
prerank,Hepatocellular carcinoma,0.31830142624960767,1.254641752852604,0.11272727272727273,0.4634480138080272,1.0,34/114,18.11%,WNT11;WNT16;HMOX1;SMARCD3;PLCG2;GSTP1;IGF1R;MYC;MAPK3;BAX;SMAD4;WNT6;TCF7;PIK3R1;SMARCA4;TXNRD2;MAP2K1;AXIN1;DVL2;DPF3;SMARCC2;GADD45A;LRP5;KEAP1;TCF7L2;SMARCC1;SMARCA2;ARID1A;GAB1;ELK1;PRKCA;SMARCD2;ACTB;MGST3
prerank,Fluid shear stress and atherosclerosis,0.3234560239004327,1.2515296531862856,0.10416666666666667,0.46240211132033343,1.0,27/98,18.28%,HMOX1;CAV1;JUN;NOS3;CALML4;GSTP1;CALML5;NFKB1;ASS1;IKBKG;PIK3R1;TXN;CYBA;HSP90AB1;MAPK13;PIAS4;KEAP1;MAPK7;PDGFA;IKBKB;PTK2;ACVR2B;CALM1;RELA;ACTB;MGST3;ACVR1
prerank,N-Glycan biosynthesis,-0.3667511714341784,-1.2489762700579,0.18032786885245902,0.5479094846636613,1.0,19/43,24.19%,ALG3;ALG8;DDOST;MAN1A2;DPAGT1;RPN2;MAN1B1;DPM2;ALG9;MGAT5;ALG6;STT3A;MAN2A1;ALG14;ALG2;DOLPP1;MAN1A1;ALG11;SRD5A3
prerank,Th1 and Th2 cell differentiation,0.35361319885570114,1.227624567474353,0.17293233082706766,0.5155747397319176,1.0,20/47,24.16%,JUN;NFKBIE;JAK3;STAT5B;MAPK3;CD3G;NFKB1;LCK;IKBKG;JAG2;MAPK13;IKBKB;ZAP70;RELA;PPP3CB;GATA3;PPP3CC;PLCG1;JAK1;TYK2
prerank,Thyroid hormone signaling pathway,-0.31996520615168,-1.2240380107536795,0.13963963963963963,0.6025987801644126,1.0,19/84,16.52%,ATP1B1;RCAN1;ATP1B2;PLN;AKT1;STAT1;BAD;MED12L;EP300;MED27;BMP4;MDM2;TSC2;ATP1B3;SLC9A1;PIK3CB;AKT3;ITGAV;MTOR
prerank,Hepatitis B,-0.2999371324077778,-1.2236871547942578,0.1,0.5800670093629521,1.0,31/119,16.00%,TGFBR1;CREB3L4;E2F3;CREB5;SOS1;SOS2;MMP9;FAS;AKT1;STAT1;ATF2;STAT4;BAD;CDK2;NFATC3;DDB2;IRAK4;YWHAZ;CASP3;EP300;DDX3X;IFNAR1;TBK1;CCNE1;CREB3L1;IL6;BIRC5;PIK3CB;CCNE2;E2F1;AKT3
prerank,Non-small cell lung cancer,-0.3495574990447313,-1.2168193433412737,0.18181818181818182,0.5792524823948849,1.0,10/53,5.89%,RARB;E2F3;SOS1;SOS2;AKT1;RASSF5;BAD;GADD45G;EML4;DDB2
prerank,Pertussis,0.36513903659861563,1.2100291238881706,0.18532818532818532,0.5566461669609694,1.0,13/45,17.71%,JUN;CALML4;NOS2;MAPK3;CALML5;NFKB1;IRAK1;NLRP3;GNAI1;MAPK13;IL23A;CALM1;RELA
prerank,Signaling pathways regulating pluripotency of stem cells,0.32464276616767923,1.2061667230806108,0.14453125,0.5569921538608745,1.0,28/86,19.62%,WNT11;WNT16;JAK3;IGF1R;MYC;MAPK3;SMAD4;HESX1;FGF2;WNT6;SMAD5;PIK3R1;FGFR3;MAP2K1;AXIN1;DVL2;NANOG;MAPK13;ID4;KLF4;SMAD1;PCGF2;ACVR2B;INHBB;ACVR1;ESRRB;ZFHX3;BMPR2
prerank,Cholesterol metabolism,-0.3966614407228941,-1.2061362226247294,0.2388663967611336,0.5888974125847634,1.0,10/29,17.23%,LDLR;CYP27A1;LIPA;TSPO;SOAT1;CD36;LDLRAP1;VDAC1;NPC2;LCAT
prerank,Shigellosis,0.3501913077919506,1.2034599036613136,0.18050541516245489,0.5545469500945935,1.0,16/55,19.09%,CD44;ARPC1B;ELMO3;MAPK3;DOCK1;NFKB1;PFN2;IKBKG;CTTN;MAPK13;CRK;IKBKB;CRKL;RELA;ACTB;WASL
prerank,Cysteine and methionine metabolism,0.3712360641261015,1.1992398246392808,0.2159090909090909,0.5573586699617371,1.0,11/38,13.84%,BCAT2;BHMT;MTR;TAT;IL4I1;AHCYL2;DNMT3A;BCAT1;AHCY;GCLC;AHCYL1
prerank,Toxoplasmosis,0.3351598146729472,1.1959016666510422,0.16541353383458646,0.5574715905865791,1.0,20/62,17.71%,HSPA6;NOS2;CASP9;PPIF;LAMA1;ALOX5;MAPK3;HSPA2;NFKB1;IRAK1;IKBKG;CASP8;GNAI1;TAB1;MAPK13;HSPA1A;IKBKB;LAMB1;BIRC3;RELA
prerank,GnRH signaling pathway,0.34613572030915263,1.1898808057069288,0.20155038759689922,0.5652610329686686,1.0,25/58,24.33%,JUN;CALML4;CAMK2G;MAPK3;CALML5;ADCY7;GNA11;MAP2K1;MAPK13;PRKACB;PLD2;MAPK7;CALM1;ELK1;PRKCA;PLA2G4B;MAP3K1;PLA2G4A;EGR1;PLCB4;MAP3K4;MMP14;RAF1;GNAS;MAP2K3
prerank,Chemokine signaling pathway,0.31159473439937124,1.1884875432050348,0.19318181818181818,0.5596536112056628,1.0,29/104,15.22%,GRK5;GNG7;CCL22;VAV1;CXCL2;GNGT1;CCL17;JAK3;GRK2;STAT5B;MAPK3;NFKB1;CCL19;ADCY7;IKBKG;CCL26;PARD3;PIK3R1;ARRB2;GNAI1;MAP2K1;PXN;GRK4;CCR4;PRKACB;CRK;CCL24;IKBKB;PTK2
prerank,Glutamatergic synapse,0.3433940645309397,1.1877288224865716,0.17407407407407408,0.5532205849519983,1.0,21/51,24.13%,GNG7;GNGT1;GRK2;MAPK3;DLGAP1;ADCY7;GNAI1;HOMER2;SLC1A3;PRKACB;PLD2;PRKCA;PLA2G4B;GLUL;PLA2G4A;PPP3CB;PPP3CC;PLCB4;GLS;GNAS;GNAI2
prerank,Serotonergic synapse,0.3489305171748963,1.1847653793147228,0.20802919708029197,0.5522491202330452,1.0,10/48,12.48%,PTGS1;GNG7;PTGS2;GNGT1;ALOX5;MAPK3;HTR2B;GNAI1;MAP2K1;PRKACB
prerank,Hepatitis C,-0.3017577366489601,-1.1752517651069099,0.17757009345794392,0.6613401731910497,1.0,17/97,9.76%,LDLR;E2F3;CLDN1;SOS1;TRADD;SOS2;FAS;AKT1;STAT1;BAD;CD81;CDK2;PIAS1;YWHAZ;CASP3;CLDN6;IFNAR1
prerank,Bile secretion,-0.3737798375724888,-1.174606198724209,0.2314410480349345,0.6408202952355697,1.0,7/30,5.13%,ATP1B1;LDLR;EPHX1;ATP1B2;ABCC3;ABCG2;KCNN2
prerank,Legionellosis,0.3651973443218344,1.1735523853982146,0.22519083969465647,0.574746385912034,1.0,11/37,19.11%,HSPA6;CXCL2;CASP9;HSPA2;NFKB1;CASP8;HSPA1A;NFKB2;EEF1A1;RELA;BCL2L13
prerank,Cushing syndrome,0.30510006502843867,1.168006522112317,0.18681318681318682,0.5814862520823673,1.0,20/92,11.32%,WNT11;HSD3B1;WNT16;CYP11A1;CAMK2G;MAPK3;CDKN2C;STAR;WNT6;ADCY7;ARMC5;GNA11;TCF7;CDKN1B;POMC;GNAI1;MAP2K1;AXIN1;PDE8A;DVL2
prerank,Notch signaling pathway,-0.3711893577163718,-1.1659179570545999,0.24152542372881355,0.6474965996869146,1.0,8/32,9.42%,RFNG;ADAM17;DTX3L;NCSTN;APH1B;EP300;APH1A;MAML1
prerank,Tight junction,0.30240923228223926,1.1647539464780847,0.19343065693430658,0.582567131461974,1.0,34/110,23.42%,TUBA3E;JUN;TJAP1;CLDN8;MICALL2;SYMPK;EZR;PARD3;PPP2R2B;TJP1;PPP2CB;CTTN;AMOT;VASP;ARHGEF18;PRKACB;TJP3;MARVELD2;AMOTL2;LLGL1;ARHGAP17;MAP3K1;ACTB;MARVELD3;LLGL2;MYH9;WASL;MYH8;RAP1A;CLDN4;MAP3K5;ACTN1;SLC9A3R1;HSPA4
prerank,Inflammatory mediator regulation of TRP channels,0.34340610433013496,1.1601502782297815,0.22727272727272727,0.5862307684617768,1.0,18/50,24.33%,P2RY2;PLCG2;CALML4;CAMK2G;CALML5;HTR2B;ADCY7;PIK3R1;MAPK13;PRKACB;CALM1;PRKCA;PLA2G4B;PLA2G4A;PLCB4;PLCG1;GNAS;MAP2K3
prerank,Cardiac muscle contraction,-0.3407365754535715,-1.1601292485615025,0.23766816143497757,0.6438444709626093,1.0,5/45,5.10%,ATP1B1;ATP1B2;MYH7;COX1;CACNA2D2
prerank,Estrogen signaling pathway,0.308303732991293,1.1565205500705276,0.22456140350877193,0.5883395387625915,1.0,32/77,24.13%,HSPA6;JUN;KRT19;NOS3;CALML4;MAPK3;CALML5;HSPA2;KRT18;ADCY7;PIK3R1;KRT15;POMC;FKBP4;GNAI1;MAP2K1;HSP90AB1;PRKACB;HSPA1A;NCOA1;CALM1;NCOA2;KRT14;NCOA3;SHC1;SP1;HSP90AA1;PLCB4;CREB3;RAF1;GNAS;GNAI2
prerank,Bacterial invasion of epithelial cells,0.33474934601741535,1.156222909176916,0.23443223443223443,0.5805085568401332,1.0,19/55,20.63%,CAV1;ARPC1B;ELMO3;DOCK1;PIK3R1;CTTN;PXN;CRK;PTK2;FN1;GAB1;CD2AP;CLTA;CRKL;ACTB;CTNNA1;WASL;SHC1;BCAR1
prerank,Phosphatidylinositol signaling system,0.31221385094091275,1.1545753447453744,0.21481481481481482,0.5766043121870315,1.0,27/73,27.67%,PLCG2;CALML4;PLCD1;ITPK1;PI4K2B;CALML5;PIK3C2B;PLCD3;INPP5D;INPPL1;PIK3R1;PIP4K2B;PIKFYVE;CALM1;PRKCA;OCRL;PI4K2A;DGKD;PLCB4;PLCG1;INPP5A;PIP4K2C;PPIP5K1;PI4KB;INPP4B;INPP5F;PLCE1
prerank,Other glycan degradation,0.4580604053377011,1.153184820742777,0.29545454545454547,0.5716269036410919,1.0,2/15,9.11%,FUCA2;GBA2
prerank,Th17 cell differentiation,0.32398545478872054,1.1521702165636205,0.2423076923076923,0.5658210538066533,1.0,25/59,24.16%,JUN;RXRA;NFKBIE;JAK3;STAT5B;MAPK3;CD3G;SMAD4;NFKB1;LCK;IKBKG;IL6R;HSP90AB1;MAPK13;IL23A;IKBKB;ZAP70;RELA;PPP3CB;GATA3;HSP90AA1;PPP3CC;PLCG1;JAK1;TYK2
prerank,Epstein-Barr virus infection,0.27890534492992186,1.1465114590592569,0.16828478964401294,0.5732596867573791,1.0,32/136,16.74%,CD19;CD44;JUN;VIM;PLCG2;TAP2;CASP9;NFKBIE;JAK3;MYC;BAX;CD3G;NFKB1;IRAK1;IKBKG;IRF7;CASP8;CDKN1B;RELB;PIK3R1;NCOR2;TAB1;MAPK13;GADD45A;BLNK;ENTPD3;SEM1;CCND3;IKBKB;TAP1;CCNA1;NFKB2
prerank,Butanoate metabolism,-0.4401402496743683,-1.145137927099568,0.3188976377952756,0.670124072868703,1.0,4/16,9.04%,BDH2;ABAT;BDH1;ECHS1
prerank,AMPK signaling pathway,-0.29899492776706893,-1.1408393244601298,0.22429906542056074,0.6644516199478997,1.0,22/85,17.19%,SCD5;PPARGC1A;CREB3L4;CREB5;AKT1;ADIPOR2;PFKM;EIF4EBP1;G6PC3;CAB39L;CD36;TSC1;PRKAB1;CREB3L1;RAB8A;TSC2;PIK3CB;AKT3;MTOR;PRKAG1;ACACA;STRADB
prerank,Glucagon signaling pathway,-0.3020798389142986,-1.1365452562158218,0.252212389380531,0.658885479410539,1.0,11/72,8.18%,LDHC;PPARGC1A;CREB3L4;CREB5;GNAQ;AKT1;ATF2;G6PC3;ITPR1;PRMT1;EP300
prerank,Gap junction,0.3300724337384359,1.135516157622699,0.2546816479400749,0.5960978560610175,1.0,13/56,14.10%,TUBA3E;TUBB6;GUCY1B1;MAPK3;HTR2B;ADCY7;GNA11;TJP1;GNAI1;MAP2K1;PRKACB;MAPK7;PDGFA
prerank,Prostate cancer,-0.2993681006826614,-1.1300354608138716,0.2191780821917808,0.6602360116679926,1.0,20/71,16.52%,CREB3L4;E2F3;CREB5;SOS1;SOS2;MMP9;AKT1;BAD;CDK2;EP300;CCNE1;CREB3L1;MDM2;FGFR2;ZEB1;PIK3CB;CCNE2;E2F1;AKT3;MTOR
prerank,Hedgehog signaling pathway,0.36889725102242843,1.1288842650315618,0.27586206896551724,0.6071905931383493,1.0,6/27,12.48%,IHH;PTCH1;GRK2;ARRB2;SMURF1;PRKACB
prerank,Oxytocin signaling pathway,0.3060910576692919,1.127367306009188,0.22627737226277372,0.6036856206155039,1.0,28/79,21.39%,GUCY1B1;PTGS2;JUN;NOS3;MYLK;CALML4;CAMK2G;MAPK3;CALML5;NPR2;CACNB3;ADCY7;CAMKK2;GNAI1;MAP2K1;PRKACB;MAPK7;EEF2;CALM1;ELK1;PRKCA;PLA2G4B;ACTB;PLA2G4A;CD38;PPP3CB;PPP3CC;PLCB4
prerank,Collecting duct acid secretion,0.40602882910842925,1.1266858625439673,0.2862453531598513,0.5980586169802512,1.0,5/21,15.58%,CA2;ATP6V0E2;ATP6V1G3;ATP6V1B1;TCIRG1
prerank,Longevity regulating pathway,-0.2992947804376752,-1.1263200557069801,0.2619047619047619,0.6543840977015201,1.0,20/73,18.43%,PPARGC1A;CRYAB;CREB3L4;CREB5;AKT1;ADIPOR2;ATF2;EIF4EBP1;TSC1;PRKAB1;CREB3L1;TSC2;EHMT2;PIK3CB;AKT3;MTOR;EIF4EBP2;PRKAG1;APPL1;ADCY3
prerank,"Glycine, serine and threonine metabolism",0.3767876069290901,1.1156767379098242,0.30434782608695654,0.6207923300187199,1.0,5/27,9.39%,GATM;BHMT;SHMT1;SRR;AOC2
prerank,Thyroid cancer,0.3770012781331925,1.1139095501694118,0.3088803088803089,0.617582473483853,1.0,8/29,14.48%,RXRA;MYC;MAPK3;BAX;TCF7;MAP2K1;GADD45A;TCF7L2
prerank,Basal transcription factors,-0.3411693294800549,-1.1128140132892188,0.3286384976525822,0.6762864799229578,1.0,15/38,30.72%,TAF9B;TAF15;GTF2H3;TBP;TAF6;TBPL1;GTF2A1L;TAF4B;TAF10;GTF2H1;TAF8;ERCC2;CDK7;GTF2E2;TAF3
prerank,Glycosphingolipid biosynthesis,-0.3748972257043045,-1.1098548895103084,0.3244444444444444,0.6684073462116422,1.0,10/25,19.31%,ST3GAL4;ST8SIA5;B4GALT4;GCNT2;FUT4;ST3GAL3;ABO;GLA;GLB1;B3GNT5
prerank,Type II diabetes mellitus,0.39661396383174174,1.108891088679929,0.31135531135531136,0.6236932071891047,1.0,11/21,28.96%,MAPK3;PIK3R1;SLC2A4;HKDC1;IKBKB;PKM;HK1;MAPK1;MAPK8;HK2;SOCS2
prerank,Olfactory transduction,0.38133855367978137,1.1071067829374388,0.3048327137546468,0.6210601462517813,1.0,7/20,12.48%,GNG7;CALML4;CAMK2G;GRK2;CALML5;ARRB2;PRKACB
prerank,Breast cancer,0.2978521375915414,1.103364905259776,0.2536764705882353,0.623379293069555,1.0,18/84,12.82%,WNT11;WNT16;JUN;IGF1R;MYC;MAPK3;BAX;FGF2;WNT6;TCF7;HEYL;PIK3R1;MAP2K1;AXIN1;JAG2;DVL2;GADD45A;LRP5
prerank,PPAR signaling pathway,0.33354373046933283,1.1029343797275595,0.28679245283018867,0.6168518682903078,1.0,9/44,10.04%,FABP2;APOA1;FABP5;RXRA;FABP7;CPT1B;NR1H3;SCD;FADS2
prerank,Phagosome,0.28221672451232827,1.1000316771141623,0.27816901408450706,0.6174515463698318,1.0,8/87,5.43%,TUBA3E;THBS4;THBS2;TUBB6;TAP2;FCGR2A;ATP6V0E2;ATP6V1G3
prerank,Ras signaling pathway,0.27397705695571956,1.0944390811136528,0.2579505300353357,0.6256891638101992,1.0,36/134,18.42%,GNG7;ABL2;PLCG2;CALML4;PAK6;GNGT1;NTF4;FLT1;TEK;IGF1R;MAPK3;CALML5;NFKB1;FGF2;RALB;IKBKG;RASA3;VEGFB;PIK3R1;FGFR3;MAP2K1;RALBP1;PRKACB;PLD2;PDGFA;RGL2;IKBKB;KITLG;GAB1;CALM1;ELK1;ZAP70;PRKCA;PLA2G4B;RELA;PLA2G4A
prerank,Neuroactive ligand-receptor interaction,0.3193232289378961,1.091495791833914,0.3046594982078853,0.6260605045769145,1.0,12/52,12.24%,NR3C1;FSHR;GABRP;P2RY2;F2;LPAR3;CNR2;HTR2B;PARD3;POMC;GCGR;GPR83
prerank,TGF-beta signaling pathway,-0.3099843305292831,-1.0905908234523498,0.2824074074074074,0.7095249933704588,1.0,10/54,12.78%,ZFYVE9;TGFBR1;ID3;ID1;HAMP;EP300;BMP4;ID2;TGIF2;RBL1
prerank,Protein digestion and absorption,-0.36098108780003535,-1.0895023739274805,0.33617021276595743,0.6956409957894328,1.0,6/31,5.95%,ATP1B1;ATP1B2;PGA5;SLC3A1;SLC3A2;COL4A2
prerank,Other types of O-glycan biosynthesis,0.3824142849298736,1.088651845384157,0.3383458646616541,0.6262853726072887,1.0,4/19,8.57%,B4GALT2;EOGT;ST6GAL1;LFNG
prerank,Sphingolipid metabolism,-0.33791988543243995,-1.0880078744226713,0.3391304347826087,0.6836524983899686,1.0,12/35,17.26%,SGPP2;CERS3;GALC;DEGS2;CERS5;ASAH1;ACER3;PLPP2;GBA;DEGS1;CERS2;GLA
prerank,Hypertrophic cardiomyopathy (HCM),0.3445899199968161,1.0879881390559558,0.350597609561753,0.6208049178996935,1.0,6/36,6.39%,ITGA3;MYH6;TPM2;TNNI3;CACNB3;LMNA
prerank,Calcium signaling pathway,0.285063830788843,1.0852051514386212,0.3161764705882353,0.6216770647541209,1.0,16/81,6.93%,NOS3;PLCG2;MYLK;CALML4;NOS2;SPHK2;PPIF;PLCD1;CAMK2G;ERBB3;CALML5;TNNC2;PLCD3;HTR2B;ADCY7;GNA11
prerank,Vascular smooth muscle contraction,0.29524107507326,1.0826855969697293,0.3225806451612903,0.6212497829376596,1.0,11/67,6.93%,GUCY1B1;NPPB;MYLK;CALML4;ACTG2;MAPK3;CALML5;NPR2;ARHGEF1;ADCY7;GNA11
prerank,Osteoclast differentiation,0.28953829498316136,1.0753902579984809,0.367816091954023,0.6338609481610151,1.0,21/76,15.17%,FOSB;JUN;PLCG2;FCGR2A;SIRPA;MAPK3;NFKB1;JUND;LCK;IKBKG;FOSL2;RELB;PIK3R1;CYBA;MAP2K1;TAB1;MAPK13;BLNK;FYN;FHL2;IKBKB
prerank,Alcoholism,-0.2863207187562308,-1.0742713570775677,0.3201754385964912,0.7090294351630866,1.0,8/68,5.17%,ADORA2B;CREB3L4;CREB5;SOS1;SOS2;ATF2;GNB5;SLC29A1
prerank,Tuberculosis,0.2702629768734928,1.070865304709645,0.2947761194029851,0.6400151188638769,1.0,15/99,8.41%,RFX5;CLEC4E;CALML4;NOS2;CASP9;SPHK2;FCGR2A;CAMK2G;MAPK3;CALML5;BAX;NFKB1;IRAK1;CASP8;MALT1
prerank,Chronic myeloid leukemia,-0.30402554539931537,-1.0692582607266912,0.3440366972477064,0.7077472216195366,1.0,9/60,5.89%,TGFBR1;E2F3;SOS1;SOS2;AKT1;BAD;GADD45G;CBL;DDB2
prerank,Human papillomavirus infection,0.25270229943503913,1.0655503198170304,0.28169014084507044,0.6469918160495695,1.0,44/201,16.16%,WNT11;WNT16;THBS4;THBS2;ITGA3;PTGS2;COL1A1;LAMA1;ATP6V0E2;MAPK3;BAX;ATP6V1G3;NFKB1;WNT6;PPP2R3A;COL1A2;TCF7;IKBKG;CASP8;CDKN1B;HEYL;PARD3;LFNG;PIK3R1;PPP2R2B;PPP2CB;MAP2K1;PXN;AXIN1;DVL2;NFX1;PRKACB;ATP6V1B1;CREBBP;TADA3;TCF7L2;LLGL1;CCND3;IKBKB;PTK2;FN1;TCIRG1;LAMB1;CCNA1
prerank,Dilated cardiomyopathy (DCM),0.3303859189197488,1.0616543675251993,0.35797665369649806,0.6494794858274786,1.0,7/37,6.63%,ITGA3;MYH6;TPM2;TNNI3;CACNB3;LMNA;ADCY7
prerank,Insulin signaling pathway,0.2742370635327966,1.0609667297523226,0.3490909090909091,0.6444366106156215,1.0,24/100,16.78%,CBLB;FBP2;CALML4;PYGB;EXOC7;MAPK3;CALML5;FASN;RHOQ;MKNK2;INPPL1;PIK3R1;PDE3B;MAP2K1;SLC2A4;PRKACB;CRK;HKDC1;PTPRF;RAPGEF1;IKBKB;CALM1;ELK1;CRKL
prerank,Complement and coagulation cascades,-0.35209246750624373,-1.0599682418907057,0.351931330472103,0.718754235540234,1.0,5/26,3.90%,CLU;PLAUR;SERPINE1;F13A1;CD55
prerank,Spliceosome,0.26434703786914054,1.0593216838715553,0.32974910394265233,0.6416738762372554,1.0,42/125,28.65%,HSPA6;RBMXL2;PRPF19;PRPF6;HSPA2;SF3B2;DHX38;LSM5;PRPF40B;HNRNPM;HSPA1A;HNRNPU;SNRNP70;SNRPG;SRSF4;TRA2A;SF3B6;SNRPF;BCAS2;CHERP;LSM6;SRSF1;LSM8;DHX8;SNRPE;SNRPB2;SRSF2;XAB2;LSM3;DDX5;DDX23;HNRNPA1;SNRPD1;PRPF31;DHX16;ZMAT2;MAGOH;SF3B3;RBM8A;PUF60;LSM7;ACIN1
prerank,Glycolysis / Gluconeogenesis,0.31941210361822625,1.0580579506817702,0.35074626865671643,0.6386217008122671,1.0,21/44,33.67%,ALDH1A3;FBP2;ALDH2;HKDC1;DLAT;PKM;HK1;PGM2;ALDH9A1;ALDH7A1;HK2;ALDOB;PGK1;PGM1;FBP1;ENO1;PDHB;AKR1A1;PFKL;TPI1;PDHA1
prerank,Inositol phosphate metabolism,0.3057761823415445,1.0531230247945178,0.37969924812030076,0.6446199042242483,1.0,22/56,27.67%,PLCG2;PLCD1;ITPK1;PI4K2B;PIK3C2B;PLCD3;INPP5D;INPPL1;FIG4;PIP4K2B;ISYNA1;PIKFYVE;OCRL;PI4K2A;PLCB4;PLCG1;INPP5A;PIP4K2C;PI4KB;INPP4B;INPP5F;PLCE1
prerank,MicroRNAs in cancer,0.2673109600575468,1.0522314562291954,0.3235294117647059,0.6404601947133762,1.0,29/114,16.94%,HMOX1;CD44;PTGS2;VIM;PLCG2;PIM1;ERBB3;MYC;ST14;NFKB1;STMN1;EZR;CDKN1B;BMF;DNMT3A;FGFR3;MAP2K1;CDCA5;CRK;CREBBP;PLAU;MAPK7;DICER1;PDGFA;IKBKB;SPRY2;MARCKS;CRKL;PRKCA
prerank,Cortisol synthesis and secretion,-0.3171283565315892,-1.0452069204475207,0.4008438818565401,0.7488729779899231,1.0,7/36,6.98%,LDLR;CREB3L4;CREB5;GNAQ;ATF2;NR4A1;ITPR1
prerank,"Valine, leucine and isoleucine degradation",0.3211385192552983,1.0433238942114273,0.38461538461538464,0.6581044876088412,1.0,12/42,21.13%,BCAT2;AOX1;AACS;IL4I1;BCAT1;HMGCS1;ALDH2;ACAA1;ACADS;ALDH9A1;ALDH7A1;OXCT1
prerank,Hippo signaling pathway,0.2712392867440991,1.0392655786011464,0.3694029850746269,0.6627573340053362,1.0,21/98,14.71%,WNT11;WNT16;WTIP;TEAD2;MYC;YWHAG;SMAD4;WNT6;TCF7;PARD3;PPP2R2B;PPP2CB;AMOT;AXIN1;DVL2;SMAD1;SMAD7;TCF7L2;LLGL1;CCND3;YWHAH
prerank,cAMP signaling pathway,-0.26543618298680893,-1.035582424981781,0.36666666666666664,0.7630785332633705,1.0,22/97,16.00%,ATP1B1;ATP1B2;PLN;CREB3L4;CREB5;ADRB2;PLD1;AKT1;BAD;EP300;MYL9;RRAS;ROCK2;CREB3L1;RAC2;ATP2B1;ATP1B3;SLC9A1;PIK3CB;CNGB3;PPP1R12A;AKT3
prerank,Leukocyte transendothelial migration,0.2832289507707046,1.0340631332857892,0.3971631205673759,0.669671976850575,1.0,23/69,24.76%,MYL7;VAV1;PLCG2;ESAM;CLDN8;EZR;PIK3R1;GNAI1;VASP;CYBA;PXN;MAPK13;PTK2;PRKCA;ACTB;CTNNA1;BCAR1;RAP1A;CLDN4;ACTN1;PLCG1;GNAI2;CYBB
prerank,Pancreatic cancer,-0.2817582123991504,-1.0309541347847433,0.41350210970464135,0.7623337090073367,1.0,8/61,5.89%,TGFBR1;E2F3;PLD1;AKT1;STAT1;BAD;GADD45G;DDB2
prerank,Chagas disease (American trypanosomiasis),0.29286133152183563,1.0307214623342273,0.3828125,0.6715822706611436,1.0,14/55,11.79%,JUN;NOS2;MAPK3;CD3G;NFKB1;IRAK1;GNA11;IKBKG;CASP8;PIK3R1;PPP2R2B;PPP2CB;GNAI1;MAPK13
prerank,Melanoma,-0.3069483574791619,-1.0267368158700882,0.4090909090909091,0.7590053523398221,1.0,11/43,16.00%,E2F3;MITF;AKT1;BAD;GADD45G;DDB2;MET;MDM2;PIK3CB;E2F1;AKT3
prerank,Arachidonic acid metabolism,0.3435251756078914,1.0248382896356798,0.41509433962264153,0.6791329623714084,1.0,4/24,5.65%,PTGS1;PTGS2;ALOX5;CBR1
prerank,Apelin signaling pathway,0.27042781734348975,1.0170682802406028,0.4263565891472868,0.6943572651208284,1.0,18/84,12.48%,GNG7;NOS3;MYLK;CALML4;NOS2;SPHK2;GNGT1;HDAC5;MAPK3;CALML5;SMAD4;ADCY7;GNAI1;PDE3B;PIK3R4;MAP2K1;ACTA2;PRKACB
prerank,ABC transporters,0.3815460560088137,1.0152546708984937,0.4594594594594595,0.6930823928858784,1.0,4/18,8.19%,ABCA3;TAP2;ABCG5;ABCC2
prerank,Salmonella infection,0.2833255529300937,1.0119782555950656,0.40875912408759124,0.6958240219675202,1.0,26/61,27.97%,ARPC1B;JUN;NOS2;CXCL2;MAPK3;NFKB1;PFN2;PLEKHM2;TJP1;KLC4;MAPK13;FLNA;RELA;ACTB;MYH9;WASL;FLNB;ARPC5;FLNC;CXCL8;DYNC1H1;KLC2;MAPK1;IL18;MAPK8;ACTG1
prerank,Relaxin signaling pathway,0.2701064238194772,1.0079142430786816,0.4432234432234432,0.7000038244317102,1.0,18/81,12.48%,GNG7;JUN;NOS3;NOS2;COL1A1;GNGT1;MAPK3;NFKB1;ADCY7;COL1A2;VEGFB;PIK3R1;ARRB2;GNAI1;MAP2K1;MAPK13;ACTA2;PRKACB
prerank,NOD-like receptor signaling pathway,0.25777079488800114,1.0069387712050075,0.43223443223443225,0.6960699369739722,1.0,20/90,12.90%,JUN;CXCL2;MAPK3;NFKB1;NLRP3;TXNIP;NLRX1;IKBKG;IRF7;CASP8;MFN2;PANX1;TXN;ATG16L1;CYBA;HSP90AB1;TAB1;MAPK13;GBP4;RBCK1
prerank,p53 signaling pathway,-0.2785249113661486,-1.000506343525055,0.4406779661016949,0.8247003447361443,1.0,20/60,17.60%,SERPINE1;FAS;GADD45G;CDK2;DDB2;EI24;CASP3;CCND2;CCNB1;RRM2;CCNB2;SIVA1;ATM;CCNE1;MDM2;TSC2;CCNE2;MDM4;SHISA5;PMAIP1
prerank,Long-term potentiation,0.302925689554954,0.9985841650297815,0.4448669201520912,0.7117792120806187,1.0,22/42,34.65%,CALML4;CAMK2G;MAPK3;CALML5;MAP2K1;PRKACB;CREBBP;CALM1;PRKCA;PPP3CB;PPP3CC;RAP1A;PLCB4;RAF1;MAPK1;CAMK2D;MAP2K2;CALM3;BRAF;ITPR2;KRAS;NRAS
prerank,Adipocytokine signaling pathway,-0.2904497297737611,-0.9971690551388981,0.4353448275862069,0.818904331820238,1.0,12/46,16.70%,PPARGC1A;TRADD;AKT1;ADIPOR2;G6PC3;ACSL4;CD36;NFKBIB;PRKAB1;AKT3;MTOR;PRKAG1
prerank,Arrhythmogenic right ventricular cardiomyopathy (ARVC),0.3293116461841981,0.9891286197034211,0.49110320284697506,0.7307515150783737,1.0,9/32,19.19%,ITGA3;CACNB3;LMNA;TCF7;DSC2;TCF7L2;ACTB;CTNNA1;PKP2
prerank,Kaposi sarcoma-associated herpesvirus infection,0.24856714717106024,0.9888697168970315,0.4748201438848921,0.7248698290434726,1.0,18/125,8.72%,GNG7;PTGS2;JUN;PLCG2;CALML4;CXCL2;CASP9;GNGT1;MYC;MAPK3;CALML5;BAX;NFKB1;FGF2;IKBKG;IRF7;CASP8;PIK3R1
prerank,Human T-cell leukemia virus 1 infection,-0.23494300456351608,-0.9882594933463831,0.43457943925233644,0.8297814291251047,1.0,32/157,16.68%,TGFBR1;MMP7;CREB3L4;E2F3;CREB5;FOSL1;AKT1;XIAP;ATF2;TSPO;CDK2;NFATC3;EP300;CCND2;IL2RB;CCNB2;TBP;ATM;CCNE1;CREB3L1;CRTC3;MSX2;IL6;VDAC1;PIK3CB;CCNE2;CDC20;E2F1;AKT3;ANAPC11;TLN2;BUB3
prerank,Malaria,0.3759522001459271,0.9876039405803598,0.4820717131474104,0.7218746480626405,1.0,2/16,0.78%,THBS4;THBS2
prerank,Small cell lung cancer,0.2700444413187402,0.9807500122817495,0.44528301886792454,0.7330799089709091,1.0,19/66,17.71%,ITGA3;PTGS2;NOS2;CASP9;RXRA;LAMA1;MYC;BAX;NFKB1;IKBKG;CDKN1B;PIK3R1;GADD45A;IKBKB;PTK2;FN1;LAMB1;BIRC3;RELA
prerank,Renal cell carcinoma,0.27807134114006204,0.9783739122630916,0.46689895470383275,0.7333003290719008,1.0,17/58,19.48%,EGLN3;JUN;PAK6;MAPK3;PIK3R1;TFE3;MAP2K1;EPAS1;CRK;CREBBP;RAPGEF1;FLCN;EGLN1;GAB1;CRKL;PRCC;PAK2
prerank,"Parathyroid hormone synthesis, secretion and action",0.2742102784745955,0.9777145351820138,0.49070631970260226,0.7286340085148316,1.0,26/65,24.13%,RXRA;MAPK3;ARHGEF1;ADCY7;GNA11;JUND;ARRB2;GNAI1;MMP15;MAP2K1;PRKACB;LRP5;SLC34A2;PLD2;TRPV5;PRKCA;EGR1;GATA3;SP1;PLCB4;CREB3;MMP14;SLC9A3R1;RAF1;GNAS;GNAI2
prerank,Pathogenic Escherichia coli infection,0.2870053046778594,0.976252992712935,0.4777777777777778,0.726406516259162,1.0,14/45,23.60%,TUBA3E;TUBB6;ARPC1B;KRT18;EZR;CTTN;FYN;PRKCA;ACTB;WASL;LY96;TUBB1;ABL1;ARPC5
prerank,Parkinson disease,0.2481585234329511,0.9757218720986275,0.4789272030651341,0.7218573682836287,1.0,44/121,32.99%,GPR37;CASP9;PPIF;NDUFA1;NDUFB1;COX7A1;GNAI1;NDUFA5;NDUFB3;PRKACB;HTRA2;NDUFC1;NDUFS4;UQCRB;COX7B2;NDUFA6;COX7B;ND3;SLC25A6;UQCRH;NDUFB4;PINK1;GNAI2;ATP8;NDUFA13;NDUFB11;APAF1;UQCRQ;NDUFS5;CYCS;NDUFB9;COX7A2;ATP5PD;ATP5PF;SLC25A4;SNCA;SDHA;UBA1;ATP5F1E;SLC18A2;NDUFC2;GNAL;COX2;NDUFA4
prerank,Insulin resistance,-0.2632340453660157,-0.9745931048509056,0.452991452991453,0.8570208092543392,1.0,17/76,17.77%,PPARGC1A;CREB3L4;CREB5;AKT1;SLC27A6;G6PC3;PPARGC1B;CD36;SLC27A3;PRKAB1;CREB3L1;IL6;PIK3CB;AKT3;MTOR;PRKAG1;MLX
prerank,Viral myocarditis,0.34320743629090816,0.9741957384250358,0.48698884758364314,0.7198251035176294,1.0,4/25,2.93%,MYH6;CAV1;ABL2;CASP9
prerank,Amyotrophic lateral sclerosis (ALS),0.3054959643910948,0.9698643411172493,0.5210727969348659,0.7250269777480093,1.0,14/35,26.40%,CASP9;BAX;NEFH;MAPK13;DAXX;SOD1;PRPH;PPP3CB;PPP3CC;MAP3K5;TOMM40L;MAP2K3;APAF1;CYCS
prerank,Human cytomegalovirus infection,-0.23269815168340274,-0.9667535831163349,0.5091743119266054,0.8657161868843118,1.0,33/151,16.52%,CXCL12;CREB3L4;E2F3;CREB5;SOS1;TAPBP;TRADD;SOS2;GNAQ;FAS;AKT1;ATF2;GNB5;NFATC3;EIF4EBP1;ITPR1;CASP3;PDIA3;CXCR4;ROCK2;TSC1;TBK1;CREB3L1;RAC2;MDM2;TSC2;IL6;CGAS;PIK3CB;E2F1;AKT3;ITGAV;MTOR
prerank,Gastric acid secretion,0.3056541818883953,0.9641395136475492,0.5140845070422535,0.7338124286154487,1.0,13/33,17.82%,CA2;MYLK;CALML4;CAMK2G;CALML5;ADCY7;EZR;ATP1A1;GNAI1;PRKACB;CALM1;PRKCA;ACTB
prerank,Endocytosis,0.22718235384058127,0.9619321498986484,0.5579710144927537,0.7331092456966755,1.0,37/183,19.41%,CBLB;GRK5;HSPA6;CAV1;WASHC1;ARPC1B;DNAJC6;IGF1R;GRK2;SNX12;HSPA2;CHMP4B;RAB11FIP1;WIPF1;PARD3;ARRB2;FGFR3;SMURF1;RAB22A;GRK4;HSPA1A;RAB31;SH3GLB2;PLD2;IGF2R;VPS36;ARFGAP2;CHMP2A;CLTA;VPS4A;BIN1;RAB11FIP4;VPS26B;CHMP7;WASL;RNF41;ZFYVE27
prerank,Wnt signaling pathway,0.25111587173071104,0.9549843768732362,0.5223367697594502,0.7446130723865845,1.0,29/93,21.96%,WNT11;WNT16;JUN;SOX17;CAMK2G;MYC;SMAD4;WNT6;TCF7;CTNNBIP1;CTBP1;CSNK2A2;AXIN1;DVL2;PRKACB;LRP5;CREBBP;TCF7L2;CCND3;PRICKLE1;TBL1X;PRKCA;RYK;RSPO3;PPP3CB;PPARD;PPP3CC;PLCB4;AXIN2
prerank,Amino sugar and nucleotide sugar metabolism,0.29564882104827767,0.9542781303667486,0.5203252032520326,0.7405823952639199,1.0,19/42,36.23%,UAP1L1;GFPT1;HKDC1;RENBP;HK1;PGM2;CYB5RL;GMDS;GMPPB;UGDH;GALE;HK2;GFPT2;PGM1;UAP1;NANS;GNE;CMAS;GNPDA1
prerank,Gastric cancer,0.25705867738335253,0.9535726917859016,0.550561797752809,0.7363665996874302,1.0,19/84,12.82%,WNT11;WNT16;RXRA;MYC;MAPK3;BAX;SMAD4;FGF2;WNT6;TCF7;CDKN1B;MLH1;PIK3R1;MAP2K1;AXIN1;DVL2;CDX2;GADD45A;LRP5
prerank,Toll-like receptor signaling pathway,0.2698005736736039,0.9521045223583835,0.5205992509363296,0.7340654092998367,1.0,12/55,11.79%,JUN;MAPK3;NFKB1;IRAK1;IRF5;IKBKG;IRF7;CASP8;PIK3R1;MAP2K1;TAB1;MAPK13
prerank,Influenza A,0.252630435350225,0.9512474527048129,0.5215686274509804,0.7302507941698179,1.0,36/88,27.97%,HSPA6;TMPRSS4;JUN;CASP9;MAPK3;HSPA2;NFKB1;NLRP3;NLRX1;IRF7;PIK3R1;MAP2K1;MAPK13;HSPA1A;PABPN1;CREBBP;IKBKB;PRKCA;RELA;ACTB;SLC25A6;HNRNPUL1;MAVS;RAF1;CPSF4;JAK1;TYK2;MAP2K3;FDPS;PML;CXCL8;CYCS;MAPK1;IL18;MAPK8;ACTG1
prerank,Glutathione metabolism,-0.2835798333175275,-0.937180449909366,0.5594713656387665,0.9413249439502424,1.0,6/39,10.28%,GPX7;GSTO1;GPX8;GSS;GSTA3;RRM2
prerank,Sphingolipid signaling pathway,0.25938410786369726,0.9360205866936565,0.5471014492753623,0.7628158838468408,1.0,20/83,14.23%,NSMAF;CERS4;NOS3;SPHK2;MAPK3;BAX;NFKB1;PPP2R3A;SGMS2;SGPP1;PIK3R1;PPP2R2B;PPP2CB;GNAI1;SMPD2;MAP2K1;SGMS1;MAPK13;PLD2;FYN
prerank,Ferroptosis,-0.2845774499379249,-0.9324075446750464,0.5657370517928287,0.9390011175512368,1.0,10/35,13.82%,MAP1LC3A;LPCAT3;SAT1;SLC3A2;ACSL4;GSS;TFRC;FTH1;ATG7;MAP1LC3B
prerank,Nicotinate and nicotinamide metabolism,-0.34301462389849546,-0.9269623783007348,0.5482456140350878,0.9381766202831396,1.0,1/17,0.48%,ENPP3
prerank,Axon guidance,0.23649669003373452,0.9235399444640735,0.6203389830508474,0.7868199746967329,1.0,30/99,24.13%,PTCH1;PLCG2;PAK6;NGEF;CAMK2G;L1CAM;MAPK3;ABLIM2;LIMK2;PARD3;PIK3R1;UNC5B;GNAI1;EPHB4;FYN;PTK2;LIMK1;PRKCA;UNC5C;RYK;PAK2;BMPR2;PPP3CB;TRPC3;PPP3CC;ABL1;RAF1;PLCG1;RASA1;GNAI2
prerank,Dopaminergic synapse,0.24480075194339598,0.9220377668517119,0.5977859778597786,0.7843307228605285,1.0,25/82,24.13%,GNG7;SCN1A;COMT;CALML4;GNGT1;CAMK2G;CALML5;PPP2R3A;PPP2R2B;PPP2CB;ARRB2;GNAI1;MAPK13;PRKACB;CALM1;PRKCA;PPP3CB;ARNTL;PPP2R5A;PPP3CC;PLCB4;CREB3;PPP2R5D;GNAS;GNAI2
prerank,Renin secretion,0.2948662369998558,0.9191143904096596,0.5813148788927336,0.7858551953220201,1.0,12/30,24.13%,GUCY1B1;CALML4;CALML5;GNAI1;PDE3B;PRKACB;CALM1;PPP3CB;PPP3CC;PLCB4;GNAS;GNAI2
prerank,RNA polymerase,-0.30434334020447074,-0.9173008260534803,0.5767634854771784,0.9493948829085853,1.0,10/27,26.97%,POLR3GL;POLR2J;POLR2C;POLR2E;POLR3H;POLR1E;POLR3K;POLR1C;POLR2K;POLR3A
prerank,Vasopressin-regulated water reabsorption,-0.2840566865064235,-0.9120344769998046,0.5528455284552846,0.9485513890574366,1.0,11/35,23.84%,CREB3L4;CREB5;DYNC1I1;DYNLL1;CREB3L1;VAMP2;ADCY3;RAB11A;CREB3L2;RAB5C;DCTN5
prerank,Rap1 signaling pathway,0.22677998606298647,0.9094460805182352,0.6328671328671329,0.8030116976868483,1.0,48/122,28.01%,CALML4;LPAR3;FLT1;TEK;IGF1R;MAPK3;CALML5;FGF2;ADCY7;PFN2;SIPA1L3;RALB;VEGFB;PARD3;PIK3R1;APBB1IP;GNAI1;VASP;FGFR3;MAP2K1;FYB1;MAPK13;CRK;RAPGEF1;PDGFA;MAGI3;KITLG;CALM1;CRKL;PRKCA;ACTB;RGS14;BCAR1;SIPA1L2;RAP1A;PLCB4;RAF1;PLCG1;GNAS;GNAI2;MAP2K3;CDH1;RAPGEF2;CTNND1;MAPK1;PLCE1;ACTG1;VEGFA
prerank,Fc epsilon RI signaling pathway,0.27417833734969715,0.9088489758546227,0.6232394366197183,0.798363541136834,1.0,16/43,24.33%,VAV1;PLCG2;ALOX5;MAPK3;INPP5D;PIK3R1;MAP2K1;MAPK13;FYN;PRKCA;PLA2G4B;PLA2G4A;LYN;RAF1;PLCG1;MAP2K3
prerank,Pentose phosphate pathway,0.31095193033104984,0.9072464961854495,0.5746268656716418,0.7962027604775852,1.0,12/26,33.64%,FBP2;TKTL2;TKTL1;PGM2;H6PD;ALDOB;PGM1;FBP1;PGD;IDNK;PFKL;RPIA
prerank,JAK-STAT signaling pathway,0.25126464979109897,0.9018292081280588,0.624,0.8030876601093168,1.0,15/66,14.62%,AOX1;IL15RA;IL11RA;PIM1;JAK3;MYC;STAT5B;PIK3R1;IL6R;CISH;PIAS4;CREBBP;IL23A;PDGFA;CCND3
prerank,Epithelial cell signaling in Helicobacter pylori infection,0.2539851871029338,0.9005140501055761,0.6313868613138686,0.800447431149285,1.0,11/58,15.58%,JUN;PLCG2;ATP6V0E2;ATP6V1G3;NFKB1;IKBKG;TJP1;MAPK13;ATP6V1B1;IKBKB;TCIRG1
prerank,Non-alcoholic fatty liver disease (NAFLD),0.22496343604715463,0.896962430721091,0.6474820143884892,0.8026108864889354,1.0,36/116,27.00%,JUN;RXRA;NR1H3;BAX;NFKB1;CASP8;MLXIPL;NDUFA1;PIK3R1;NDUFB1;IL6R;COX7A1;NDUFA5;NDUFB3;NDUFC1;NDUFS4;UQCRB;IKBKB;COX7B2;NDUFA6;COX7B;DDIT3;RELA;UQCRH;NDUFB4;MAP3K5;MLXIP;NDUFA13;NDUFB11;UQCRQ;CXCL8;NDUFS5;GSK3A;CYCS;NDUFB9;COX7A2
prerank,Transcriptional misregulation in cancer,0.2301324070805093,0.8961143682317865,0.631578947368421,0.7987775480422326,1.0,35/105,21.83%,WNT16;RXRA;FLT1;IGF1R;MYC;BAX;ETV6;NFKB1;CDKN2C;CDKN1B;DUSP6;TFE3;LMO2;FUS;EWSR1;GADD45A;CDK14;SMAD1;PLAU;PDGFA;IGFBP3;PTK2;CCNA1;DDIT3;BIRC3;TSPAN7;RELA;MYCN;PRCC;KDM6A;BCL2A1;BMP2K;SP1;DDX5;FUT8
prerank,Viral carcinogenesis,0.22089018608922567,0.895300489895928,0.7016949152542373,0.7952065674988475,1.0,29/135,17.74%,JUN;HDAC7;JAK3;SCIN;HDAC5;DDB1;STAT5B;YWHAG;MAPK3;BAX;NFKB1;HDAC10;IKBKG;IRF7;CASP8;CDKN1B;SRF;PIK3R1;GSN;PXN;CCR4;PRKACB;CREBBP;CCND3;YWHAH;CCNA1;NFKB2;RELA;PKM
prerank,Necroptosis,0.2395851427417252,0.8938976166526553,0.6814814814814815,0.7926809236755653,1.0,32/81,29.57%,JAK3;PYGB;CAMK2G;STAT5B;BAX;NLRP3;CHMP4B;CASP8;HSP90AB1;MLKL;RBCK1;CHMP2A;BIRC3;VPS4A;PLA2G4B;GLUL;SLC25A6;CHMP7;PLA2G4A;AIFM1;HSP90AA1;JAK1;TYK2;PARP1;CYBB;CHMP3;CAPN2;CAMK2D;MAPK8;SLC25A4;SQSTM1;FAF1
prerank,Fanconi anemia pathway,-0.2566325914659105,-0.8936802564732594,0.646551724137931,0.9865674445328384,1.0,18/48,27.04%,RAD51C;RMI1;ATRIP;BRCA2;RPA1;SLX1A;PMS2;ERCC1;FANCC;WDR48;FANCL;RPA2;POLH;POLI;REV3L;RAD51;CENPX;BRCA1
prerank,Bladder cancer,0.28395519538221964,0.8889053593179002,0.6627450980392157,0.798633971932058,1.0,6/31,10.68%,DAPK3;MYC;MAPK3;FGFR3;DAPK1;MAP2K1
prerank,Acute myeloid leukemia,0.26611623614746377,0.8880891242000517,0.6666666666666666,0.7948014049916826,1.0,15/49,17.71%,PIM1;MYC;STAT5B;MAPK3;NFKB1;TCF7;IKBKG;DUSP6;PIK3R1;MAP2K1;PIM2;TCF7L2;IKBKB;CCNA1;RELA
prerank,Amphetamine addiction,0.2828249169883488,0.8873427438097459,0.6579925650557621,0.790770682766664,1.0,5/38,5.18%,FOSB;JUN;CALML4;CAMK2G;CALML5
prerank,TNF signaling pathway,-0.2361464505109886,-0.8846183371040798,0.6757990867579908,0.9962407240763201,1.0,8/70,4.44%,CREB3L4;CREB5;TRADD;MMP9;FAS;AKT1;ATF2;ITCH
prerank,Adherens junction,0.24718886535104787,0.8802383000442444,0.6551724137931034,0.8010298057602142,1.0,26/61,27.97%,IGF1R;MAPK3;SMAD4;TCF7;PARD3;NECTIN4;CSNK2A2;TJP1;WASF3;BAIAP2;CREBBP;PTPRF;FYN;TCF7L2;YES1;ACTB;CTNNA1;WASL;ACTN1;NLK;CDH1;CTNND1;MAPK1;PTPN1;PTPRJ;ACTG1
prerank,Homologous recombination,-0.26606283425799493,-0.87943647408138,0.6875,0.9960351066286859,1.0,14/40,28.83%,RAD51C;BABAM2;BRCA2;RPA1;RAD54B;POLD2;ATM;NBN;RPA2;BABAM1;RAD51B;RAD51;BRCA1;BLM
prerank,Terpenoid backbone biosynthesis,0.3143592396003066,0.8744862485469846,0.6575875486381323,0.8075886705006504,1.0,5/20,14.91%,PMVK;MVD;HMGCS1;MVK;NUS1
prerank,Ether lipid metabolism,-0.2832842869889429,-0.8742609479729752,0.6506550218340611,0.9948436901499749,1.0,9/27,20.57%,SELENOI;PLD1;PLD3;PLA2G7;CEPT1;PLPP2;PLA2G6;LPCAT2;PLPP1
prerank,Ribosome biogenesis in eukaryotes,-0.24678917510329992,-0.8709952177212915,0.6830357142857143,0.9881621254309202,1.0,12/68,14.51%,SPATA5;RPP40;NXF1;REXO1;XRN1;NXT1;UTP15;UTP4;CSNK2B;NVL;CSNK2A1;WDR3
prerank,Human immunodeficiency virus 1 infection,0.21860507562896056,0.8697006882308416,0.7481203007518797,0.8115260867304651,1.0,33/152,16.94%,GNG7;JUN;PLCG2;TAP2;CALML4;CASP9;PAK6;GNGT1;DDB1;MAPK3;CALML5;BAX;CD3G;LIMK2;NFKB1;IRAK1;GNA11;IKBKG;CASP8;PIK3R1;GNAI1;MAP2K1;PXN;TAB1;MAPK13;CRK;IKBKB;PTK2;TAP1;LIMK1;CALM1;CRKL;PRKCA
prerank,Huntington disease,-0.2042606787106195,-0.859566940499761,0.7972350230414746,1.0,1.0,20/160,12.89%,PPARGC1A;CREB3L4;DNAH12;DNAH14;CREB5;NRF1;GNAQ;COX1;ITPR1;DNAH8;CASP3;EP300;POLR2J;NDUFS8;AP2S1;TBP;CREB3L1;COX6B2;POLR2C;POLR2E
prerank,Prolactin signaling pathway,-0.26424308298707055,-0.8578545919174243,0.6923076923076923,0.9907467675964097,1.0,11/42,17.72%,SOS1;SOS2;AKT1;STAT1;CCND2;CYP17A1;SOCS1;PIK3CB;AKT3;IRF1;GALT
prerank,Circadian rhythm,-0.29207055529274706,-0.8536638218766831,0.6451612903225806,0.9864054825316536,1.0,5/20,16.70%,CLOCK;BHLHE40;BTRC;PRKAB1;PRKAG1
prerank,Glycerolipid metabolism,-0.2555730949910321,-0.8529351528695841,0.6733870967741935,0.9741418643829848,1.0,10/37,17.26%,MBOAT2;AKR1B1;AGPAT5;MOGAT1;PLPP5;AGPAT3;PLPP2;LCLAT1;DGAT1;GLA
prerank,Nucleotide excision repair,-0.25802061028190515,-0.8510990986795334,0.6594827586206896,0.9645540528595421,1.0,15/43,27.29%,DDB2;GTF2H3;RPA1;POLD2;POLE2;POLE3;ERCC1;POLE;RPA2;RFC5;RAD23A;ERCC8;GTF2H1;ERCC2;CDK7
prerank,Colorectal cancer,-0.22721770681127534,-0.8479182288647358,0.7763713080168776,0.9576798499829526,1.0,16/69,17.60%,TGFBR1;SOS1;SOS2;AKT1;BAD;GADD45G;DDB2;CASP3;RAC2;BCL2L11;BIRC5;PIK3CB;AKT3;MTOR;APPL1;PMAIP1
prerank,SNARE interactions in vesicular transport,0.2833326293577106,0.847784953353787,0.6788321167883211,0.8501540826198755,1.0,10/30,27.74%,VAMP1;VTI1A;VAMP5;BET1L;STX6;STX3;STX4;STX7;STX8;USE1
prerank,RNA transport,-0.20344400562334775,-0.8475413374603228,0.7956989247311828,0.9449645366230798,1.0,41/136,28.76%,NDC1;RPP40;NUP58;NXF1;EIF4EBP1;SRRM1;EIF2B1;GEMIN5;SMN2;NUP35;NXT1;GEMIN7;EIF1;NUP153;NUP43;THOC1;TRNT1;DDX39B;NUP50;EIF4EBP2;RPP14;NXT2;NUP54;NUP98;EIF3I;SNUPN;SUMO3;RAE1;EIF2B2;EIF3F;UBE2I;NUP88;RPP25L;NUP37;NMD3;RPP21;PHAX;SAP18;GEMIN8;EIF3J;AAAS
prerank,Oocyte meiosis,-0.21820412105988993,-0.8449510784959368,0.7838983050847458,0.937452119979964,1.0,19/89,16.07%,CPEB1;SPDYC;CDK2;SMC1A;ITPR1;PLK1;FBXO5;AURKA;YWHAZ;CCNB1;CCNB2;BTRC;MAD2L2;CCNE1;YWHAE;SGO1;CCNE2;CDC20;ANAPC11
prerank,mTOR signaling pathway,-0.20858908669920187,-0.8432258023249409,0.8361344537815126,0.9286833912737075,1.0,25/112,17.19%,SKP2;SOS1;SOS2;AKT1;RRAGD;EIF4EBP1;SLC3A2;WNT10A;FNIP2;SLC38A9;FZD3;CAB39L;MLST8;TSC1;FNIP1;LAMTOR1;TTI1;TSC2;TBC1D7;SGK1;PIK3CB;WNT5B;AKT3;MTOR;STRADB
prerank,Base excision repair,-0.27701262590603526,-0.8417155039866842,0.652542372881356,0.9192656260078694,1.0,9/29,19.60%,SMUG1;POLD2;NEIL3;POLE2;LIG3;POLE3;POLE;PARP2;MPG
prerank,Fructose and mannose metabolism,0.28341578268165374,0.8405167645746152,0.6853932584269663,0.8590373695865994,1.0,12/26,33.34%,FBP2;TKFC;HKDC1;HK1;GMDS;GMPPB;HK2;ALDOB;FBP1;ENOSF1;PFKL;TPI1
prerank,Aminoacyl-tRNA biosynthesis,-0.28798422744867286,-0.8397804688716998,0.6954545454545454,0.911217183770883,1.0,8/24,29.43%,YARS2;FARSB;QRSL1;GATC;RARS2;SEPSECS;FARS2;DARS2
prerank,Rheumatoid arthritis,0.2533387439622391,0.8267963170958013,0.7388059701492538,0.8807039113176929,1.0,5/40,5.43%,JUN;ATP6V0E2;FLT1;TEK;ATP6V1G3
prerank,Vibrio cholerae infection,0.24830236247997226,0.8218621378520347,0.7606177606177607,0.8844169085361316,1.0,11/44,17.82%,PLCG2;ATP6V0E2;ATP6V1G3;SEC61G;TJP1;PRKACB;ATP6V1B1;TCIRG1;PRKCA;PDIA4;ACTB
prerank,Glioma,0.24097493222118652,0.8196255313975097,0.7849056603773585,0.882136134928415,1.0,13/54,16.94%,PLCG2;CALML4;CAMK2G;IGF1R;MAPK3;CALML5;BAX;PIK3R1;MAP2K1;GADD45A;PDGFA;CALM1;PRKCA
prerank,Synaptic vesicle cycle,0.24611329776192886,0.8101429170956772,0.762589928057554,0.8937174651296694,1.0,10/46,17.92%,SLC6A1;ATP6V0E2;ATP6V1G3;SLC1A3;ATP6V1B1;UNC13B;SLC6A11;TCIRG1;CLTA;STX3
prerank,Fatty acid degradation,0.2539640191073069,0.8061772666174728,0.7805755395683454,0.8949980081338184,1.0,9/32,21.60%,CPT1B;ALDH2;ACAA1;ACADS;ACSL6;ALDH9A1;ALDH7A1;GCDH;CPT1C
prerank,Galactose metabolism,-0.2724351623633654,-0.8040944494250513,0.7214611872146118,0.9703912476098759,1.0,6/20,18.96%,AKR1B1;PFKM;G6PC3;GLA;GALT;GLB1
prerank,Protein processing in endoplasmic reticulum,-0.1966104996896329,-0.8004214984753381,0.8981481481481481,0.9645810302134884,1.0,44/143,26.32%,CRYAB;YOD1;SIL1;SEC61A2;DDOST;UBQLN2;MAN1A2;SEC24B;RPN2;PDIA3;OS9;ERO1A;UBE2G1;MAN1B1;UBE4B;ATF6;ERP29;SEC61A1;STUB1;UBE2D4;STT3A;SEC31B;EIF2AK1;DERL3;MBTPS2;UBE2J1;DERL1;DNAJB1;UBE2J2;SAR1B;SEC23A;LMAN2;DERL2;UBE2D1;CUL1;MAN1A1;SSR2;RAD23A;UBE2D3;MAP2K7;SSR3;XBP1;DNAJC10;DNAJC3
prerank,mRNA surveillance pathway,0.2172119003545217,0.7991585561058144,0.8368055555555556,0.9008906643702357,1.0,22/73,26.87%,UPF3A;SYMPK;PPP2R3A;CSTF2T;PPP2R2B;PPP2CB;PABPC4;PABPC1;PABPN1;DAZAP1;CSTF2;UPF1;SMG5;PPP2R5A;SMG7;GSPT2;PPP2R5D;PNN;CPSF4;CPSF1;MAGOH;RBM8A
prerank,Choline metabolism in cancer,-0.21227712329134982,-0.7964455066952276,0.8511627906976744,0.9591348278699114,1.0,17/71,16.52%,SOS1;SOS2;PLD1;AKT1;EIF4EBP1;PIP5K1A;GPCPD1;TSC1;SLC44A4;LYPLA1;WASF1;RAC2;TSC2;PLPP2;PIK3CB;AKT3;MTOR
prerank,Apoptosis,0.20203978025054808,0.7961519054680287,0.8597122302158273,0.9002657563252165,1.0,36/105,28.09%,TUBA3E;JUN;CASP9;MAPK3;BAX;NFKB1;LMNA;IKBKG;CASP8;PIK3R1;LMNB2;MAP2K1;DFFB;DAXX;GADD45A;HTRA2;IKBKB;DDIT3;BIRC3;RELA;ACTB;SPTAN1;AIFM1;BCL2A1;MAP3K5;DFFA;RAF1;PARP1;APAF1;BAK1;CYCS;MAPK1;CAPN2;MAPK8;ACTG1;CTSZ
prerank,Endometrial cancer,0.2371873297363642,0.7958006644937501,0.7757352941176471,0.8948948368740733,1.0,11/49,14.48%,CASP9;MYC;MAPK3;BAX;TCF7;MLH1;PIK3R1;MAP2K1;AXIN1;GADD45A;TCF7L2
prerank,Natural killer cell mediated cytotoxicity,-0.2287862192149591,-0.7933724346675679,0.8158995815899581,0.9524561191504788,1.0,9/47,12.81%,SOS1;FCER1G;SOS2;FAS;IFNGR1;CASP3;IFNAR1;LAT;RAC2
prerank,Cholinergic synapse,0.2256744890015112,0.7854461427177448,0.8394160583941606,0.9059802077067363,1.0,11/55,14.23%,GNG7;GNGT1;CAMK2G;MAPK3;ADCY7;GNA11;PIK3R1;GNAI1;MAP2K1;PRKACB;FYN
prerank,Starch and sucrose metabolism,0.28542059774990725,0.7841080302852611,0.7670250896057348,0.9023576267306503,1.0,2/20,4.34%,GBA3;PYGB
prerank,Pyruvate metabolism,-0.25598380069884147,-0.779359726271661,0.8034188034188035,0.9630792561654733,1.0,1/28,0.46%,LDHC
prerank,Cocaine addiction,-0.2593120979513,-0.7775991382806829,0.7929515418502202,0.9543142762668971,1.0,3/25,3.84%,CREB3L4;CREB5;ATF2
prerank,Mannose type O-glycan biosynthesis,0.2900068247745766,0.7766358792431486,0.7303370786516854,0.908788532368383,1.0,1/16,1.75%,B4GALT2
prerank,Peroxisome,0.2047475469415653,0.7372561116338925,0.8924731182795699,0.9559555704398303,1.0,11/68,15.78%,PMVK;NOS2;PEX10;PEX26;PEX6;PEX5;MVK;CRAT;ACAA1;SOD1;ACSL6
prerank,Thermogenesis,0.17344837344177863,0.7366877096157862,0.9572953736654805,0.9506589758417128,1.0,49/192,24.70%,NPPB;SMARCD3;KLB;CPT1B;MGLL;ADCY7;SLC25A29;PNPLA2;NDUFA1;NDUFB1;COX7A1;SMARCA4;NDUFA5;NDUFB3;ATP5ME;DPF3;MAPK13;SMARCC2;PRKACB;NDUFC1;NDUFS4;UQCRB;SMARCC1;SMARCA2;ARID1A;ACSL6;COX7B2;NDUFA6;COX7B;COX17;ND3;COX20;SMARCD2;ACTB;UQCRH;NDUFB4;RPS6;NDUFAF2;KDM3A;CPT1C;CREB3;MAP3K5;COX19;GNAS;ATP8;MAP2K3;NDUFA13;NDUFB11;ATP5MF
prerank,Protein export,-0.2514817423940492,-0.7346661408183022,0.8669724770642202,1.0,1.0,7/23,26.53%,SEC61A2;OXA1L;SEC61A1;SPCS2;SRPRB;SRPRA;SEC11A
prerank,RIG-I-like receptor signaling pathway,0.2245774489821872,0.7273328283581905,0.8953068592057761,0.9554133280411468,1.0,10/39,17.71%,NFKB1;NLRX1;IKBKG;IRF7;CASP8;TKFC;MAPK13;IKBKB;MAP3K1;RELA
prerank,Pyrimidine metabolism,-0.21302996383402045,-0.7202836438332688,0.9036697247706422,1.0,1.0,17/43,31.87%,ENPP3;UCK2;RRM2;CTPS2;DCTD;ENPP1;DTYMK;TK1;DCK;NME6;UMPS;UPRT;DHODH;NME3;DCTPP1;PNP;NME2
prerank,Phospholipase D signaling pathway,0.1910946314545855,0.7141682852474048,0.950530035335689,0.9629511681644538,1.0,18/82,18.42%,F2;PLCG2;SPHK2;LPAR3;MAPK3;ADCY7;RALB;PIK3R1;MAP2K1;PLD2;PDGFA;FYN;KITLG;GAB1;PRKCA;PLA2G4B;DGKD;PLA2G4A
prerank,Ubiquitin mediated proteolysis,-0.17394481317668983,-0.709924770136582,0.990521327014218,1.0,1.0,39/125,24.92%,SKP2;XIAP;ITCH;CBL;PIAS1;DDB2;CUL5;UBE2S;UBE2G1;SOCS1;UBE4B;BTRC;STUB1;UBE2D4;MDM2;UBE2E2;UBE2C;CDC20;ANAPC11;BIRC2;UBE2J1;PIAS2;UBE2J2;FANCL;CBLC;CDC23;UBOX5;UBA6;UBE2N;MID1;UBE2D1;UBE2F;CUL2;CUL1;SIAH1;UBE2M;UBE2I;UBE2D3;BIRC6
prerank,Progesterone-mediated oocyte maturation,0.19281716444027602,0.7077639667284085,0.9576923076923077,0.9633138930183676,1.0,11/70,12.48%,IGF1R;MAPK3;ADCY7;CPEB2;PIK3R1;GNAI1;PDE3B;MAP2K1;HSP90AB1;MAPK13;PRKACB
prerank,Inflammatory bowel disease (IBD),0.2622584640040651,0.69929933190973,0.8509803921568627,0.9653595567192352,1.0,5/16,19.96%,JUN;NFKB1;IL23A;RELA;GATA3
prerank,Central carbon metabolism in cancer,0.19982795045689217,0.6979297120621449,0.9027777777777778,0.9609321411567233,1.0,26/50,37.60%,MYC;MAPK3;PIK3R1;FGFR3;MAP2K1;HKDC1;PKM;HK1;GLS;RAF1;MAPK1;SLC7A5;HK2;MAP2K2;PDK1;PDHB;PFKL;PDHA1;ERBB2;KIT;KRAS;NRAS;LDHA;PTEN;PIK3R2;TIGAR
prerank,Autophagy,-0.17245969548296436,-0.6974273714211865,0.9786324786324786,1.0,1.0,19/109,16.52%,BECN2;AKT1;RRAGD;BAD;ITPR1;VMP1;RRAS;MLST8;LAMP2;TSC1;GABARAP;ATG7;TSC2;UVRAG;MTMR14;PIK3CB;CTSD;AKT3;MTOR
prerank,Lysine degradation,0.20794703834979028,0.6892502484184192,0.9377289377289377,0.9618609398751058,1.0,15/49,25.01%,PLOD2;EZH1;SETMAR;AASS;ALDH2;SETD7;PHYKPL;ALDH9A1;ALDH7A1;NSD3;GCDH;EZH2;SUV39H1;NSD2;KMT2A
prerank,Oxidative phosphorylation,0.17000843352430148,0.6801792065801261,0.9782608695652174,0.9626929639906867,1.0,33/121,29.07%,ATP6V0E2;ATP6V1G3;NDUFA1;NDUFB1;COX7A1;NDUFA5;NDUFB3;ATP12A;ATP5ME;ATP6V1B1;NDUFC1;NDUFS4;UQCRB;TCIRG1;COX7B2;NDUFA6;COX7B;COX17;ND3;UQCRH;NDUFB4;ATP8;NDUFA13;NDUFB11;ATP5MF;UQCRQ;NDUFS5;NDUFB9;COX7A2;ATP5PD;ATP5PF;SDHA;ATP6V1H
prerank,Purine metabolism,0.18603634795796423,0.6786162603989634,0.9611307420494699,0.9584735339539813,1.0,16/78,20.94%,GUCY1B1;AK1;NPR2;ADCY7;GMPR;CANT1;PDE3B;PDE8A;AK7;ENTPD3;NUDT16;PKM;AK3;PGM2;XDH;RRM2B
prerank,Mitophagy,-0.18439334989388662,-0.6683501269461484,0.9814814814814815,1.0,1.0,8/61,13.63%,MITF;BECN2;CALCOCO2;RRAS;TBK1;GABARAP;CSNK2B;CSNK2A1
prerank,Alzheimer disease,-0.16144167759177674,-0.6566420509489265,0.995575221238938,1.0,1.0,16/131,12.28%,GNAQ;FAS;RTN3;ADAM17;COX1;BAD;ATP2A3;ITPR1;NCSTN;CASP3;APH1B;APH1A;NDUFS8;ATF6;MME;COX6B2
prerank,RNA degradation,-0.17383479256515932,-0.6497099214834378,0.9827586206896551,1.0,1.0,10/71,13.78%,BTG4;PFKM;XRN1;CNOT9;LSM2;PNPT1;PNLDC1;CNOT4;CNOT8;CNOT3
prerank,Proteasome,-0.18649301117717387,-0.632478110324592,0.9700854700854701,0.9999053986812427,1.0,21/42,43.12%,PSMF1;PSMB10;PSMB2;PSMD8;PSMC4;PSMB5;PSME1;PSME3;PSMD12;PSMC1;PSMB1;PSMB3;PSMA5;PSMD14;PSMA1;PSMD7;PSMD11;ADRM1;PSMD4;PSMD1;PSMA7
prerank,"Alanine, aspartate and glutamate metabolism",0.2230493766195003,0.6294816432719751,0.9426229508196722,0.9809164992185756,1.0,6/20,21.84%,IL4I1;ASS1;GFPT1;GLUL;ALDH4A1;GLS
prerank,Cytosolic DNA-sensing pathway,-0.18856646574340838,-0.6197646010973086,0.9650655021834061,0.9938779869766345,1.0,12/35,26.97%,POLR3GL;NFKBIB;TBK1;POLR2E;IL6;CGAS;CASP1;POLR3H;POLR3K;POLR1C;POLR2K;POLR3A
prerank,DNA replication,-0.19384332549731864,-0.6164623329726948,0.9673469387755103,0.984129169690029,1.0,9/35,22.84%,RPA1;POLD2;POLA2;POLE2;POLE3;POLE;RPA2;RFC5;PRIM1
prerank,Mismatch repair,-0.21328329080213476,-0.6046047767062168,0.9533898305084746,0.9776915937417131,1.0,6/22,20.43%,RPA1;POLD2;PMS2;MLH3;RPA2;RFC5
prerank,Glyoxylate and dicarboxylate metabolism,0.18383466080950267,0.5572695990987271,0.9710144927536232,0.9955177442751032,1.0,5/25,23.23%,SHMT1;ACO1;GLUL;HYI;PCCA
prerank,Citrate cycle (TCA cycle),0.16954266855256955,0.5154207180880225,0.9963636363636363,0.9948370171913373,1.0,27/27,83.09%,ACO1;DLAT;PC;OGDH;ACLY;SDHA;IDH2;PDHB;PDHA1;PCK2;ACO2;SUCLG2;IDH3A;IDH3B;IDH3G;SUCLG1;SDHB;DLD;FH;CS;SDHC;MDH2;MDH1;SDHD;IDH1;DLST;SUCLA2
